STOCK TITAN
  1. Home
  2. Sec-filings
  3. PSNYW
  4. [6-K/A] Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) Amended Current Report (Foreign Issuer)

[6-K/A] Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) Amended Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K/A
Rhea-AI Filing Summary

Kura Oncology, Inc. (KURA) filed an 8-K to disclose that, on June 27, 2025, it executed a Co-Promotion and Medical Affairs Agreement with Kyowa Kirin, Inc. covering U.S. commercialization of its oral menin inhibitor ziftomenib for acute myeloid leukemia and other hematologic malignancies. The agreement operates under the previously announced November 20, 2024 Collaboration and License Agreement.

Main commercial terms

  • Co-promotion rights: Kyowa Kirin US will handle up to a specified share of sales details and must meet minimum detailing thresholds with qualified representatives.
  • Cost sharing: Both companies will split all U.S. co-promotion and medical affairs expenses 50/50.
  • Medical affairs leadership: Kura will lead U.S. medical affairs, with input from Kyowa Kirin; the parties will jointly craft a health economics and outcomes research strategy.
  • Term & termination: The pact lasts until the earlier of (i) mutual decision to cease commercialization or (ii) expiration of the U.S. collaboration term—defined as the latest of patent expiry, regulatory exclusivity expiry, or 10 years after first commercial sale. It terminates automatically if the broader Collaboration Agreement ends, and either side may end it for an uncured material breach.

The full agreement, with confidential portions redacted, will be filed as an exhibit to Kura’s Form 10-Q for the quarter ending June 30, 2025.

Kura Oncology, Inc. (KURA) ha presentato un modulo 8-K per comunicare che, il 27 giugno 2025, ha stipulato un Accordo di Co-Promozione e Affari Medici con Kyowa Kirin, Inc. relativo alla commercializzazione negli Stati Uniti del suo inibitore orale di menina ziftomenib per la leucemia mieloide acuta e altre neoplasie ematologiche. L'accordo si basa sul precedente Accordo di Collaborazione e Licenza annunciato il 20 novembre 2024.

Termini commerciali principali

  • Diritti di co-promozione: Kyowa Kirin US gestirà fino a una quota specificata delle attività di dettaglio delle vendite e dovrà raggiungere soglie minime di attività con rappresentanti qualificati.
  • Condivisione dei costi: Entrambe le società divideranno al 50% tutte le spese relative alla co-promozione e agli affari medici negli Stati Uniti.
  • Leadership negli affari medici: Kura guiderà gli affari medici negli Stati Uniti, con il contributo di Kyowa Kirin; le parti elaboreranno congiuntamente una strategia di ricerca in economia sanitaria e risultati clinici.
  • Durata e risoluzione: L'accordo ha validità fino al primo tra (i) decisione reciproca di cessare la commercializzazione o (ii) scadenza del termine di collaborazione negli Stati Uniti, definito come la più tardiva tra la scadenza del brevetto, la fine dell'esclusività regolatoria o 10 anni dalla prima vendita commerciale. Si risolve automaticamente se termina l'Accordo di Collaborazione più ampio, e ciascuna parte può recedere in caso di violazione materiale non sanata.

L'accordo completo, con le parti riservate oscurate, sarà depositato come allegato al modulo 10-Q di Kura per il trimestre terminante il 30 giugno 2025.

Kura Oncology, Inc. (KURA) presentó un formulario 8-K para informar que, el 27 de junio de 2025, firmó un Acuerdo de Co-Promoción y Asuntos Médicos con Kyowa Kirin, Inc. para la comercialización en EE.UU. de su inhibidor oral de menina ziftomenib para leucemia mieloide aguda y otras malignidades hematológicas. El acuerdo se basa en el previamente anunciado Acuerdo de Colaboración y Licencia del 20 de noviembre de 2024.

Términos comerciales principales

  • Derechos de co-promoción: Kyowa Kirin US gestionará hasta una cuota específica de las actividades de detalle de ventas y deberá cumplir con mínimos de visitas con representantes calificados.
  • Compartición de costos: Ambas compañías dividirán al 50% todos los gastos de co-promoción y asuntos médicos en EE.UU.
  • Liderazgo en asuntos médicos: Kura liderará los asuntos médicos en EE.UU., con aportes de Kyowa Kirin; las partes desarrollarán conjuntamente una estrategia de investigación en economía de la salud y resultados.
  • Duración y terminación: El acuerdo dura hasta lo que ocurra primero entre (i) decisión mutua de cesar la comercialización o (ii) expiración del término de colaboración en EE.UU., definido como lo último entre la expiración de patentes, exclusividad regulatoria o 10 años desde la primera venta comercial. Termina automáticamente si finaliza el Acuerdo de Colaboración general, y cualquiera de las partes puede rescindirlo por incumplimiento material no subsanado.

El acuerdo completo, con las secciones confidenciales redactadas, se presentará como anexo al formulario 10-Q de Kura para el trimestre que termina el 30 de junio de 2025.

Kura Oncology, Inc. (KURA)는 2025년 6월 27일에 Kyowa Kirin, Inc.와 급성 골수성 백혈병 및 기타 혈액 악성종양 치료를 위한 경구용 메닌 억제제 ziftomenib의 미국 내 상업화를 위한 공동 판촉 및 의료 업무 계약을 체결했다고 8-K 보고서를 통해 공개했습니다. 이 계약은 2024년 11월 20일 발표된 협력 및 라이선스 계약에 기반합니다.

주요 상업 조건

  • 공동 판촉 권리: Kyowa Kirin US는 지정된 판매 활동 비율까지 담당하며, 자격을 갖춘 대표들과 최소 활동 기준을 충족해야 합니다.
  • 비용 분담: 양사는 미국 내 공동 판촉 및 의료 업무 비용을 50:50으로 분담합니다.
  • 의료 업무 리더십: Kura가 미국 내 의료 업무를 주도하며 Kyowa Kirin의 의견을 반영하고, 양측은 건강 경제 및 결과 연구 전략을 공동 수립합니다.
  • 계약 기간 및 종료: 계약 기간은 (i) 상업화 중단에 대한 상호 합의 또는 (ii) 미국 협력 기간 만료 중 빠른 시점까지이며, 협력 기간은 특허 만료, 규제 독점권 만료, 또는 최초 상업 판매 후 10년 중 가장 늦은 시점을 기준으로 합니다. 더 넓은 협력 계약 종료 시 자동 종료되며, 어느 한 쪽이 중대한 위반을 시정하지 않을 경우 계약 해지가 가능합니다.

기밀 부분이 편집된 완전한 계약서는 2025년 6월 30일 종료 분기용 Kura의 10-Q 양식 제출 시 부속서로 첨부될 예정입니다.

Kura Oncology, Inc. (KURA) a déposé un formulaire 8-K pour annoncer qu’au 27 juin 2025, elle a signé un Accord de Co-Promotion et d’Affaires Médicales avec Kyowa Kirin, Inc. concernant la commercialisation aux États-Unis de son inhibiteur oral de menine ziftomenib pour la leucémie myéloïde aiguë et d’autres hémopathies malignes. Cet accord s’inscrit dans le cadre de l’Accord de Collaboration et de Licence annoncé le 20 novembre 2024.

Principaux termes commerciaux

  • Droits de co-promotion : Kyowa Kirin US prendra en charge jusqu’à une part définie des activités de promotion et devra atteindre des seuils minimaux de visites avec des représentants qualifiés.
  • Partage des coûts : Les deux entreprises se répartiront à parts égales (50/50) toutes les dépenses liées à la co-promotion et aux affaires médicales aux États-Unis.
  • Direction des affaires médicales : Kura dirigera les affaires médicales aux États-Unis, avec les contributions de Kyowa Kirin ; les parties élaboreront conjointement une stratégie en économie de la santé et recherche sur les résultats.
  • Durée et résiliation : L’accord est valable jusqu’au premier des événements suivants : (i) décision mutuelle d’arrêter la commercialisation ou (ii) expiration de la période de collaboration aux États-Unis — définie comme la dernière date parmi l’expiration des brevets, la fin de l’exclusivité réglementaire ou 10 ans après la première vente commerciale. Il prend fin automatiquement si l’Accord de Collaboration plus large est résilié, et chaque partie peut y mettre fin en cas de manquement matériel non corrigé.

L’accord complet, avec les parties confidentielles expurgées, sera déposé en annexe au formulaire 10-Q de Kura pour le trimestre se terminant le 30 juin 2025.

Kura Oncology, Inc. (KURA) hat in einer 8-K-Meldung bekanntgegeben, dass am 27. Juni 2025 ein Co-Promotion- und Medical Affairs-Vertrag mit Kyowa Kirin, Inc. abgeschlossen wurde, der die Vermarktung des oralen Menin-Inhibitors ziftomenib in den USA für akute myeloische Leukämie und andere hämatologische Malignome regelt. Der Vertrag basiert auf dem zuvor am 20. November 2024 angekündigten Kooperations- und Lizenzvertrag.

Wesentliche kommerzielle Bedingungen

  • Co-Promotion-Rechte: Kyowa Kirin US übernimmt bis zu einem festgelegten Anteil der Verkaufsaktivitäten und muss Mindestanforderungen an die Betreuung durch qualifizierte Vertreter erfüllen.
  • Kostenaufteilung: Beide Unternehmen teilen sich alle US-amerikanischen Kosten für Co-Promotion und Medical Affairs zu je 50 %.
  • Leitung der Medical Affairs: Kura führt die Medical Affairs in den USA mit Unterstützung von Kyowa Kirin; gemeinsam wird eine Strategie für Gesundheitsökonomie und Outcome-Forschung entwickelt.
  • Laufzeit & Kündigung: Die Vereinbarung gilt bis zum früheren Zeitpunkt von (i) gemeinsamer Entscheidung zur Einstellung der Vermarktung oder (ii) Ablauf der US-Kooperationsdauer – definiert als das späteste Datum zwischen Patentablauf, regulatorischem Exklusivitätsende oder 10 Jahren nach dem ersten kommerziellen Verkauf. Sie endet automatisch, wenn der übergeordnete Kooperationsvertrag endet, und jede Partei kann bei nicht behobener wesentlicher Vertragsverletzung kündigen.

Der vollständige Vertrag, mit geschwärzten vertraulichen Teilen, wird als Anlage zum 10-Q-Bericht von Kura für das Quartal zum 30. Juni 2025 eingereicht.

Positive
  • Experienced partner secured: Kyowa Kirin US will co-promote ziftomenib, potentially accelerating market penetration.
  • 50/50 cost split: Equal sharing of promotional and medical-affairs expenses reduces Kura’s cash burn.
  • Long commercialization horizon: Agreement end tied to patent/regulatory exclusivity or 10-year post-launch window, securing support through peak sales phase.
Negative
  • Undisclosed financials: No revenue-sharing or milestone details were revealed, limiting visibility into economic upside.
  • Dependency risk: Co-Promotion Agreement terminates automatically if the broader Collaboration Agreement is terminated.
  • Obligatory detailing thresholds: Failure to meet minimum detailing or other breaches could allow the counterpart to terminate, adding operational risk.

Insights

TL;DR: Equal-cost U.S. co-promotion with Kyowa Kirin broadens ziftomenib reach and limits spend—net positive.

The agreement adds an experienced oncology partner at launch, giving Kura immediate access to Kyowa Kirin’s field force while halving promotional and medical-affairs costs. Cost symmetry preserves Kura’s cash runway, and shared HEOR work may strengthen payer value dossiers. No revenue-share mechanics are disclosed, limiting near-term financial visibility, but the structure materially reduces commercial execution risk without ceding primary control. Termination tied to patent life or regulatory exclusivity provides a long window—effectively the critical commercialization period. Overall, strategically accretive with modest contractual risk.

TL;DR: Co-promotion leverages Kyowa Kirin detailing capacity; Kura retains medical leadership—sound launch blueprint.

Kyowa Kirin’s responsibility for a defined percentage of calls ensures adequate share-of-voice in a niche AML market where rapid hematologist adoption is key. Minimum detailing covenants mitigate under-performance risk. By keeping medical affairs leadership, Kura safeguards clinical messaging while drawing on Kyowa Kirin’s infrastructure—an optimal split for a first-in-class menin inhibitor. Shared costs align incentives, though equal expense burden may still be significant if large teams are deployed. Automatic termination if the base collaboration dissolves is standard but concentrates dependency risk on the master agreement’s stability.

Kura Oncology, Inc. (KURA) ha presentato un modulo 8-K per comunicare che, il 27 giugno 2025, ha stipulato un Accordo di Co-Promozione e Affari Medici con Kyowa Kirin, Inc. relativo alla commercializzazione negli Stati Uniti del suo inibitore orale di menina ziftomenib per la leucemia mieloide acuta e altre neoplasie ematologiche. L'accordo si basa sul precedente Accordo di Collaborazione e Licenza annunciato il 20 novembre 2024.

Termini commerciali principali

  • Diritti di co-promozione: Kyowa Kirin US gestirà fino a una quota specificata delle attività di dettaglio delle vendite e dovrà raggiungere soglie minime di attività con rappresentanti qualificati.
  • Condivisione dei costi: Entrambe le società divideranno al 50% tutte le spese relative alla co-promozione e agli affari medici negli Stati Uniti.
  • Leadership negli affari medici: Kura guiderà gli affari medici negli Stati Uniti, con il contributo di Kyowa Kirin; le parti elaboreranno congiuntamente una strategia di ricerca in economia sanitaria e risultati clinici.
  • Durata e risoluzione: L'accordo ha validità fino al primo tra (i) decisione reciproca di cessare la commercializzazione o (ii) scadenza del termine di collaborazione negli Stati Uniti, definito come la più tardiva tra la scadenza del brevetto, la fine dell'esclusività regolatoria o 10 anni dalla prima vendita commerciale. Si risolve automaticamente se termina l'Accordo di Collaborazione più ampio, e ciascuna parte può recedere in caso di violazione materiale non sanata.

L'accordo completo, con le parti riservate oscurate, sarà depositato come allegato al modulo 10-Q di Kura per il trimestre terminante il 30 giugno 2025.

Kura Oncology, Inc. (KURA) presentó un formulario 8-K para informar que, el 27 de junio de 2025, firmó un Acuerdo de Co-Promoción y Asuntos Médicos con Kyowa Kirin, Inc. para la comercialización en EE.UU. de su inhibidor oral de menina ziftomenib para leucemia mieloide aguda y otras malignidades hematológicas. El acuerdo se basa en el previamente anunciado Acuerdo de Colaboración y Licencia del 20 de noviembre de 2024.

Términos comerciales principales

  • Derechos de co-promoción: Kyowa Kirin US gestionará hasta una cuota específica de las actividades de detalle de ventas y deberá cumplir con mínimos de visitas con representantes calificados.
  • Compartición de costos: Ambas compañías dividirán al 50% todos los gastos de co-promoción y asuntos médicos en EE.UU.
  • Liderazgo en asuntos médicos: Kura liderará los asuntos médicos en EE.UU., con aportes de Kyowa Kirin; las partes desarrollarán conjuntamente una estrategia de investigación en economía de la salud y resultados.
  • Duración y terminación: El acuerdo dura hasta lo que ocurra primero entre (i) decisión mutua de cesar la comercialización o (ii) expiración del término de colaboración en EE.UU., definido como lo último entre la expiración de patentes, exclusividad regulatoria o 10 años desde la primera venta comercial. Termina automáticamente si finaliza el Acuerdo de Colaboración general, y cualquiera de las partes puede rescindirlo por incumplimiento material no subsanado.

El acuerdo completo, con las secciones confidenciales redactadas, se presentará como anexo al formulario 10-Q de Kura para el trimestre que termina el 30 de junio de 2025.

Kura Oncology, Inc. (KURA)는 2025년 6월 27일에 Kyowa Kirin, Inc.와 급성 골수성 백혈병 및 기타 혈액 악성종양 치료를 위한 경구용 메닌 억제제 ziftomenib의 미국 내 상업화를 위한 공동 판촉 및 의료 업무 계약을 체결했다고 8-K 보고서를 통해 공개했습니다. 이 계약은 2024년 11월 20일 발표된 협력 및 라이선스 계약에 기반합니다.

주요 상업 조건

  • 공동 판촉 권리: Kyowa Kirin US는 지정된 판매 활동 비율까지 담당하며, 자격을 갖춘 대표들과 최소 활동 기준을 충족해야 합니다.
  • 비용 분담: 양사는 미국 내 공동 판촉 및 의료 업무 비용을 50:50으로 분담합니다.
  • 의료 업무 리더십: Kura가 미국 내 의료 업무를 주도하며 Kyowa Kirin의 의견을 반영하고, 양측은 건강 경제 및 결과 연구 전략을 공동 수립합니다.
  • 계약 기간 및 종료: 계약 기간은 (i) 상업화 중단에 대한 상호 합의 또는 (ii) 미국 협력 기간 만료 중 빠른 시점까지이며, 협력 기간은 특허 만료, 규제 독점권 만료, 또는 최초 상업 판매 후 10년 중 가장 늦은 시점을 기준으로 합니다. 더 넓은 협력 계약 종료 시 자동 종료되며, 어느 한 쪽이 중대한 위반을 시정하지 않을 경우 계약 해지가 가능합니다.

기밀 부분이 편집된 완전한 계약서는 2025년 6월 30일 종료 분기용 Kura의 10-Q 양식 제출 시 부속서로 첨부될 예정입니다.

Kura Oncology, Inc. (KURA) a déposé un formulaire 8-K pour annoncer qu’au 27 juin 2025, elle a signé un Accord de Co-Promotion et d’Affaires Médicales avec Kyowa Kirin, Inc. concernant la commercialisation aux États-Unis de son inhibiteur oral de menine ziftomenib pour la leucémie myéloïde aiguë et d’autres hémopathies malignes. Cet accord s’inscrit dans le cadre de l’Accord de Collaboration et de Licence annoncé le 20 novembre 2024.

Principaux termes commerciaux

  • Droits de co-promotion : Kyowa Kirin US prendra en charge jusqu’à une part définie des activités de promotion et devra atteindre des seuils minimaux de visites avec des représentants qualifiés.
  • Partage des coûts : Les deux entreprises se répartiront à parts égales (50/50) toutes les dépenses liées à la co-promotion et aux affaires médicales aux États-Unis.
  • Direction des affaires médicales : Kura dirigera les affaires médicales aux États-Unis, avec les contributions de Kyowa Kirin ; les parties élaboreront conjointement une stratégie en économie de la santé et recherche sur les résultats.
  • Durée et résiliation : L’accord est valable jusqu’au premier des événements suivants : (i) décision mutuelle d’arrêter la commercialisation ou (ii) expiration de la période de collaboration aux États-Unis — définie comme la dernière date parmi l’expiration des brevets, la fin de l’exclusivité réglementaire ou 10 ans après la première vente commerciale. Il prend fin automatiquement si l’Accord de Collaboration plus large est résilié, et chaque partie peut y mettre fin en cas de manquement matériel non corrigé.

L’accord complet, avec les parties confidentielles expurgées, sera déposé en annexe au formulaire 10-Q de Kura pour le trimestre se terminant le 30 juin 2025.

Kura Oncology, Inc. (KURA) hat in einer 8-K-Meldung bekanntgegeben, dass am 27. Juni 2025 ein Co-Promotion- und Medical Affairs-Vertrag mit Kyowa Kirin, Inc. abgeschlossen wurde, der die Vermarktung des oralen Menin-Inhibitors ziftomenib in den USA für akute myeloische Leukämie und andere hämatologische Malignome regelt. Der Vertrag basiert auf dem zuvor am 20. November 2024 angekündigten Kooperations- und Lizenzvertrag.

Wesentliche kommerzielle Bedingungen

  • Co-Promotion-Rechte: Kyowa Kirin US übernimmt bis zu einem festgelegten Anteil der Verkaufsaktivitäten und muss Mindestanforderungen an die Betreuung durch qualifizierte Vertreter erfüllen.
  • Kostenaufteilung: Beide Unternehmen teilen sich alle US-amerikanischen Kosten für Co-Promotion und Medical Affairs zu je 50 %.
  • Leitung der Medical Affairs: Kura führt die Medical Affairs in den USA mit Unterstützung von Kyowa Kirin; gemeinsam wird eine Strategie für Gesundheitsökonomie und Outcome-Forschung entwickelt.
  • Laufzeit & Kündigung: Die Vereinbarung gilt bis zum früheren Zeitpunkt von (i) gemeinsamer Entscheidung zur Einstellung der Vermarktung oder (ii) Ablauf der US-Kooperationsdauer – definiert als das späteste Datum zwischen Patentablauf, regulatorischem Exklusivitätsende oder 10 Jahren nach dem ersten kommerziellen Verkauf. Sie endet automatisch, wenn der übergeordnete Kooperationsvertrag endet, und jede Partei kann bei nicht behobener wesentlicher Vertragsverletzung kündigen.

Der vollständige Vertrag, mit geschwärzten vertraulichen Teilen, wird als Anlage zum 10-Q-Bericht von Kura für das Quartal zum 30. Juni 2025 eingereicht.

December 31true00018840822024-06-30Polestar Automotive Holding UK PLC (the “Company”) is filing this Amendment No. 1 on Form 6-K (this “Amendment” or “Form 6-K/A”) to amend the Report on Form 6-K originally filed by the Company with the Securities and Exchange Commission (the “SEC”) on September 30, 2024 (the “Original Report”). Specifically, this Amendment (i) amends and restates its Management’s Discussion and Analysis of Financial Conditions and Results of Operations for the six months ended June 30, 2024 and 2023 (the “Affected Interim Periods”) filed as Exhibit 99.1 to the Original Report, and (ii) amends and restates the Company’s previously issued unaudited condensed consolidated financial statements for the Affected Interim Periods filed as Exhibit 99.2 to the Original Report. The amended and restated Management’s Discussion and Analysis of Financial Conditions and Results of Operations and unaudited condensed consolidated financial statements sections for the Affected Interim Periods are included as Exhibit 99.1 and 99.2, respectively, to this Form 6-K/A.The Company has restated certain information presented in its annual report on Form 20-F for the years ended December 31, 2022 and December 31, 2023 (“the Restated Financial Statements”) and made certain other changes to reflect the Restated Financial Statements, the effects of the Restated Financial Statements and related matters on Form 20-F/A filed with the SEC on April 23, 2025 (the "20-F/A"). Additionally, on May 9, 2025, the Company filed its Consolidated Financial Statements with the SEC as of December 31, 2024 and 2023 and for each of the years in the three-year period ended December 31, 2024 in its annual report on Form 20-F. Investors and other readers should rely only on the financial information and other related disclosures regarding the six months ended June 30, 2023 and June 30, 2024 contained in this Form 6-K/A and should not rely on the Original Report nor any previously issued or filed reports, press releases, presentations or similar communications containing financial information or other related disclosures from the Original Report.iso4217:USDiso4217:USDxbrli:sharespsny:marketxbrli:purepsny:tranchepsny:vehiclexbrli:sharesiso4217:GBPxbrli:sharespsny:voteiso4217:CNYiso4217:EUR00018840822024-01-012024-06-3000018840822023-01-012023-06-300001884082psny:ClassASharesMember2024-01-012024-06-300001884082psny:ClassASharesMember2023-01-012023-06-300001884082psny:ClassBSharesMember2024-01-012024-06-300001884082psny:ClassBSharesMember2023-01-012023-06-3000018840822024-06-3000018840822023-12-310001884082ifrs-full:ClassesOfShareCapitalDomain2022-12-310001884082ifrs-full:OtherEquityInterestMember2022-12-310001884082ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-12-310001884082ifrs-full:RetainedEarningsMember2022-12-3100018840822022-12-310001884082ifrs-full:RetainedEarningsMember2023-01-012023-06-300001884082ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-01-012023-06-300001884082ifrs-full:ClassesOfShareCapitalDomain2023-01-012023-06-300001884082ifrs-full:OtherEquityInterestMember2023-01-012023-06-300001884082ifrs-full:ClassesOfShareCapitalDomain2023-06-300001884082ifrs-full:OtherEquityInterestMember2023-06-300001884082ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-06-300001884082ifrs-full:RetainedEarningsMember2023-06-3000018840822023-06-300001884082ifrs-full:ClassesOfShareCapitalDomain2023-12-310001884082ifrs-full:OtherEquityInterestMember2023-12-310001884082ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-12-310001884082ifrs-full:RetainedEarningsMember2023-12-310001884082ifrs-full:RetainedEarningsMember2024-01-012024-06-300001884082ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2024-01-012024-06-300001884082ifrs-full:ClassesOfShareCapitalDomain2024-01-012024-06-300001884082ifrs-full:OtherEquityInterestMember2024-01-012024-06-300001884082ifrs-full:ClassesOfShareCapitalDomain2024-06-300001884082ifrs-full:OtherEquityInterestMember2024-06-300001884082ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2024-06-300001884082ifrs-full:RetainedEarningsMember2024-06-300001884082psny:PolestarAutomotiveHoldingUKPLCParentMemberpsny:PolestarAutomotiveHoldingLimitedFormerParentMember2024-01-012024-06-300001884082psny:PolestarAutomotiveHoldingUKPLCParentMemberpsny:ExternalInvestorsMember2024-01-012024-06-300001884082psny:PolestarAutomotiveHoldingUKPLCParentMemberpsny:PolestarAutomotiveHoldingLimitedFormerParentMember2023-01-012023-12-310001884082psny:PolestarAutomotiveHoldingUKPLCParentMemberpsny:ExternalInvestorsMember2023-01-012023-12-310001884082psny:ClassC2AmericanDepositarySharesMember2024-06-300001884082psny:ClassC2AmericanDepositarySharesMember2024-01-012024-06-300001884082psny:BinomialLatticeOptionPricingModelMember2024-01-012024-06-300001884082psny:MonteCarloMember2024-01-012024-06-300001884082psny:MonteCarloMember2024-06-300001884082psny:GoresGuggenheimIncBusinessCombinationAgreementBCAMemberpsny:MonteCarloMember2024-01-012024-06-300001884082psny:ClassC2AmericanDepositarySharesMemberpsny:MonteCarloMember2024-06-300001884082ifrs-full:VehiclesMember2024-01-012024-06-300001884082ifrs-full:VehiclesMember2023-01-012023-06-300001884082psny:SoftwareAndPerformanceEngineeredKitsMember2024-01-012024-06-300001884082psny:SoftwareAndPerformanceEngineeredKitsMember2023-01-012023-06-300001884082psny:CarbonCreditsMember2024-01-012024-06-300001884082psny:CarbonCreditsMember2023-01-012023-06-300001884082psny:VehicleLeasingMember2024-01-012024-06-300001884082psny:VehicleLeasingMember2023-01-012023-06-300001884082psny:OtherRevenueMember2024-01-012024-06-300001884082psny:OtherRevenueMember2023-01-012023-06-300001884082psny:UnrelatedCustomerMemberpsny:RevenueMember2023-01-012023-06-300001884082psny:SalesGeneratedObligationMember2024-01-012024-06-300001884082psny:SalesGeneratedObligationMember2023-01-012023-06-300001884082psny:DeferredRevenueExtendedServiceMember2023-12-310001884082psny:DeferredRevenueConnectedServicesMember2023-12-310001884082psny:DeferredRevenueOperatingLeasesAndOtherMember2023-12-310001884082psny:DeferredRevenueExtendedServiceMember2024-01-012024-06-300001884082psny:DeferredRevenueConnectedServicesMember2024-01-012024-06-300001884082psny:DeferredRevenueOperatingLeasesAndOtherMember2024-01-012024-06-300001884082psny:DeferredRevenueExtendedServiceMember2024-06-300001884082psny:DeferredRevenueConnectedServicesMember2024-06-300001884082psny:DeferredRevenueOperatingLeasesAndOtherMember2024-06-300001884082country:GB2024-01-012024-06-300001884082country:GB2023-01-012023-06-300001884082country:SE2024-01-012024-06-300001884082country:SE2023-01-012023-06-300001884082country:US2024-01-012024-06-300001884082country:US2023-01-012023-06-300001884082country:DE2024-01-012024-06-300001884082country:DE2023-01-012023-06-300001884082country:CN2024-01-012024-06-300001884082country:CN2023-01-012023-06-300001884082country:NO2024-01-012024-06-300001884082country:NO2023-01-012023-06-300001884082country:BE2024-01-012024-06-300001884082country:BE2023-01-012023-06-300001884082country:NL2024-01-012024-06-300001884082country:NL2023-01-012023-06-300001884082country:CA2024-01-012024-06-300001884082country:CA2023-01-012023-06-300001884082country:DK2024-01-012024-06-300001884082country:DK2023-01-012023-06-300001884082country:AU2024-01-012024-06-300001884082country:AU2023-01-012023-06-300001884082country:KR2024-01-012024-06-300001884082country:KR2023-01-012023-06-300001884082country:CH2024-01-012024-06-300001884082country:CH2023-01-012023-06-300001884082country:FI2024-01-012024-06-300001884082country:FI2023-01-012023-06-300001884082country:IT2024-01-012024-06-300001884082country:IT2023-01-012023-06-300001884082psny:OtherRegionsMember2024-01-012024-06-300001884082psny:OtherRegionsMember2023-01-012023-06-300001884082country:SE2024-06-300001884082country:SE2023-12-310001884082country:CN2024-06-300001884082country:CN2023-12-310001884082country:GB2024-06-300001884082country:GB2023-06-300001884082country:DE2024-06-300001884082country:DE2023-06-300001884082country:US2024-06-300001884082country:US2023-06-300001884082psny:OtherRegionsMember2024-06-300001884082psny:OtherRegionsMember2023-06-300001884082psny:PolestarTechnologyPolestarAndNanjingJiangningEconomicAndTechnologicalDevelopmentZoneMemberifrs-full:RelatedPartiesMember2024-02-290001884082ifrs-full:RelatedPartiesMemberpsny:PolestarTechnologyPolestarAndNanjingJiangningEconomicAndTechnologicalDevelopmentZoneMembersrt:MinimumMember2024-02-290001884082ifrs-full:RelatedPartiesMemberpsny:PolestarTechnologyPolestarAndNanjingJiangningEconomicAndTechnologicalDevelopmentZoneMembersrt:MaximumMember2024-02-290001884082psny:PolestarTechnologyPolestarAndNanjingJiangningEconomicAndTechnologicalDevelopmentZoneMemberifrs-full:RelatedPartiesMember2024-02-292024-09-160001884082psny:PolestarTimesTechnologyMemberifrs-full:RelatedPartiesMember2024-01-012024-06-300001884082psny:PolestarTimesTechnologyMemberifrs-full:RelatedPartiesMember2023-01-012023-12-310001884082psny:PolestarTechnologyMember2023-12-310001884082psny:PolestarTechnologyMember2024-01-012024-06-300001884082psny:PolestarTechnologyMember2024-06-300001884082ifrs-full:LandAndBuildingsMembersrt:MinimumMember2024-01-012024-06-300001884082ifrs-full:LandAndBuildingsMembersrt:MaximumMember2024-01-012024-06-300001884082ifrs-full:LandMember2024-01-012024-06-300001884082ifrs-full:MachineryMembersrt:MinimumMember2024-01-012024-06-300001884082ifrs-full:MachineryMembersrt:MaximumMember2024-01-012024-06-300001884082ifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2023-12-310001884082ifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMemberifrs-full:MachineryMember2023-12-310001884082ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMember2023-12-310001884082ifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2024-01-012024-06-300001884082ifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMemberifrs-full:MachineryMember2024-01-012024-06-300001884082ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMember2024-01-012024-06-300001884082ifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2024-06-300001884082ifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMemberifrs-full:MachineryMember2024-06-300001884082ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMember2024-06-300001884082ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LandAndBuildingsMember2023-12-310001884082ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:MachineryMember2023-12-310001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:RightofuseAssetsMember2023-12-310001884082ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LandAndBuildingsMember2024-01-012024-06-300001884082ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:MachineryMember2024-01-012024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:RightofuseAssetsMember2024-01-012024-06-300001884082ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LandAndBuildingsMember2024-06-300001884082ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:MachineryMember2024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:RightofuseAssetsMember2024-06-300001884082ifrs-full:LandAndBuildingsMemberifrs-full:RightofuseAssetsMember2024-06-300001884082ifrs-full:MachineryMemberifrs-full:RightofuseAssetsMember2024-06-300001884082ifrs-full:RightofuseAssetsMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMember2023-12-310001884082ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2023-12-310001884082ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2024-06-300001884082ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2023-12-310001884082ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2024-06-300001884082ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2023-12-310001884082ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2024-06-300001884082ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2023-12-310001884082ifrs-full:LaterThanFiveYearsMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMember2023-12-310001884082ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2023-12-310001884082ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2024-01-012024-06-300001884082ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:VehiclesMember2023-12-310001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:VehiclesMember2024-01-012024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:VehiclesMember2024-06-300001884082ifrs-full:VehiclesMember2024-06-300001884082psny:EarnOutSharesMember2024-01-012024-06-300001884082psny:EarnOutSharesMember2023-01-012023-06-300001884082psny:ClassC1OrdinarySharesMember2024-01-012024-06-300001884082psny:ClassC1OrdinarySharesMember2023-01-012023-06-300001884082psny:ClassC2AmericanDepositarySharesMember2024-01-012024-06-300001884082psny:ClassC2AmericanDepositarySharesMember2023-01-012023-06-300001884082psny:PerformanceStockUnitsMember2024-01-012024-06-300001884082psny:PerformanceStockUnitsMember2023-01-012023-06-300001884082ifrs-full:RestrictedShareUnitsMember2024-01-012024-06-300001884082ifrs-full:RestrictedShareUnitsMember2023-01-012023-06-300001884082psny:MarketingConsultingServicesAgreementMember2024-01-012024-06-300001884082psny:MarketingConsultingServicesAgreementMember2023-01-012023-06-300001884082psny:RestrictedStockAwardsMember2024-01-012024-06-300001884082psny:RestrictedStockAwardsMember2023-01-012023-06-300001884082ifrs-full:GrossCarryingAmountMemberpsny:InternallyDevelopedIntellectualPropertyMember2023-12-310001884082ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2023-12-310001884082ifrs-full:GrossCarryingAmountMemberpsny:AcquiredIntellectualPropertyMember2023-12-310001884082ifrs-full:GrossCarryingAmountMember2023-12-310001884082ifrs-full:GrossCarryingAmountMemberpsny:InternallyDevelopedIntellectualPropertyMember2024-01-012024-06-300001884082ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2024-01-012024-06-300001884082ifrs-full:GrossCarryingAmountMemberpsny:AcquiredIntellectualPropertyMember2024-01-012024-06-300001884082ifrs-full:GrossCarryingAmountMember2024-01-012024-06-300001884082ifrs-full:GrossCarryingAmountMemberpsny:InternallyDevelopedIntellectualPropertyMember2024-06-300001884082ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2024-06-300001884082ifrs-full:GrossCarryingAmountMemberpsny:AcquiredIntellectualPropertyMember2024-06-300001884082ifrs-full:GrossCarryingAmountMember2024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberpsny:InternallyDevelopedIntellectualPropertyMember2023-12-310001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2023-12-310001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberpsny:AcquiredIntellectualPropertyMember2023-12-310001884082ifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberpsny:InternallyDevelopedIntellectualPropertyMember2024-01-012024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2024-01-012024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberpsny:AcquiredIntellectualPropertyMember2024-01-012024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMember2024-01-012024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberpsny:InternallyDevelopedIntellectualPropertyMember2024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberpsny:AcquiredIntellectualPropertyMember2024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMember2024-06-300001884082psny:InternallyDevelopedIntellectualPropertyMember2023-12-310001884082ifrs-full:ComputerSoftwareMember2023-12-310001884082psny:AcquiredIntellectualPropertyMember2023-12-310001884082psny:InternallyDevelopedIntellectualPropertyMember2024-06-300001884082ifrs-full:ComputerSoftwareMember2024-06-300001884082psny:AcquiredIntellectualPropertyMember2024-06-300001884082psny:InvestingActivitiesMember2024-01-012024-06-300001884082psny:InvestingActivitiesMemberpsny:TradePayablesMember2024-01-012024-06-300001884082ifrs-full:GoodwillMember2023-12-310001884082psny:TrademarkMember2023-12-310001884082ifrs-full:GoodwillMember2024-01-012024-06-300001884082psny:TrademarkMember2024-01-012024-06-300001884082ifrs-full:GoodwillMember2024-06-300001884082psny:TrademarkMember2024-06-300001884082ifrs-full:LandAndBuildingsMember2024-06-300001884082ifrs-full:LandAndBuildingsMember2023-12-310001884082ifrs-full:MachineryMember2024-06-300001884082ifrs-full:MachineryMember2023-12-310001884082ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2023-12-310001884082ifrs-full:GrossCarryingAmountMemberifrs-full:MachineryMember2023-12-310001884082ifrs-full:GrossCarryingAmountMemberpsny:MachineryUnderDevelopmentMember2023-12-310001884082ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2024-01-012024-06-300001884082ifrs-full:GrossCarryingAmountMemberifrs-full:MachineryMember2024-01-012024-06-300001884082ifrs-full:GrossCarryingAmountMemberpsny:MachineryUnderDevelopmentMember2024-01-012024-06-300001884082ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2024-06-300001884082ifrs-full:GrossCarryingAmountMemberifrs-full:MachineryMember2024-06-300001884082ifrs-full:GrossCarryingAmountMemberpsny:MachineryUnderDevelopmentMember2024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LandAndBuildingsMember2023-12-310001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:MachineryMember2023-12-310001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberpsny:MachineryUnderDevelopmentMember2023-12-310001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LandAndBuildingsMember2024-01-012024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:MachineryMember2024-01-012024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberpsny:MachineryUnderDevelopmentMember2024-01-012024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LandAndBuildingsMember2024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:MachineryMember2024-06-300001884082ifrs-full:AccumulatedDepreciationAndAmortisationMemberpsny:MachineryUnderDevelopmentMember2024-06-300001884082psny:MachineryUnderDevelopmentMember2024-06-300001884082ifrs-full:Level1OfFairValueHierarchyMemberifrs-full:InvestmentPropertyMember2024-06-300001884082ifrs-full:Level2OfFairValueHierarchyMemberifrs-full:InvestmentPropertyMember2024-06-300001884082ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:InvestmentPropertyMember2024-06-300001884082ifrs-full:InvestmentPropertyMember2024-06-300001884082ifrs-full:Level1OfFairValueHierarchyMemberifrs-full:InvestmentPropertyMember2023-12-310001884082ifrs-full:Level2OfFairValueHierarchyMemberifrs-full:InvestmentPropertyMember2023-12-310001884082ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:InvestmentPropertyMember2023-12-310001884082ifrs-full:InvestmentPropertyMember2023-12-310001884082ifrs-full:Level1OfFairValueHierarchyMember2024-06-300001884082ifrs-full:Level2OfFairValueHierarchyMember2024-06-300001884082ifrs-full:Level3OfFairValueHierarchyMember2024-06-300001884082ifrs-full:Level1OfFairValueHierarchyMember2023-12-310001884082ifrs-full:Level2OfFairValueHierarchyMember2023-12-310001884082ifrs-full:Level3OfFairValueHierarchyMember2023-12-310001884082ifrs-full:Level1OfFairValueHierarchyMemberpsny:EarnOutRightsMember2024-06-300001884082ifrs-full:Level2OfFairValueHierarchyMemberpsny:EarnOutRightsMember2024-06-300001884082ifrs-full:Level3OfFairValueHierarchyMemberpsny:EarnOutRightsMember2024-06-300001884082psny:EarnOutRightsMember2024-06-300001884082ifrs-full:Level1OfFairValueHierarchyMemberpsny:EarnOutRightsMember2023-12-310001884082ifrs-full:Level2OfFairValueHierarchyMemberpsny:EarnOutRightsMember2023-12-310001884082ifrs-full:Level3OfFairValueHierarchyMemberpsny:EarnOutRightsMember2023-12-310001884082psny:EarnOutRightsMember2023-12-310001884082psny:ClassC1OrdinarySharesMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2024-06-300001884082psny:ClassC1OrdinarySharesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2024-06-300001884082psny:ClassC1OrdinarySharesMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2024-06-300001884082psny:ClassC1OrdinarySharesMemberifrs-full:OrdinarySharesMember2024-06-300001884082psny:ClassC1OrdinarySharesMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2023-12-310001884082psny:ClassC1OrdinarySharesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2023-12-310001884082psny:ClassC1OrdinarySharesMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2023-12-310001884082psny:ClassC1OrdinarySharesMemberifrs-full:OrdinarySharesMember2023-12-310001884082psny:ClassC2AmericanDepositarySharesMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2024-06-300001884082psny:ClassC2AmericanDepositarySharesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2024-06-300001884082psny:ClassC2AmericanDepositarySharesMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2024-06-300001884082psny:ClassC2AmericanDepositarySharesMemberifrs-full:OrdinarySharesMember2024-06-300001884082psny:ClassC2AmericanDepositarySharesMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2023-12-310001884082psny:ClassC2AmericanDepositarySharesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2023-12-310001884082psny:ClassC2AmericanDepositarySharesMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:OrdinarySharesMember2023-12-310001884082psny:ClassC2AmericanDepositarySharesMemberifrs-full:OrdinarySharesMember2023-12-310001884082psny:CashAndCashEquivalentsRestrictedMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001884082psny:CashAndCashEquivalentsRestrictedMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001884082ifrs-full:TradeReceivablesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001884082ifrs-full:TradeReceivablesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001884082psny:AccruedIncomeDueFromRelatedPartiesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001884082psny:AccruedIncomeDueFromRelatedPartiesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001884082psny:OtherCurrentReceivablesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001884082psny:OtherCurrentReceivablesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001884082psny:OtherNonCurrentReceivablesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001884082psny:OtherNonCurrentReceivablesMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001884082psny:RestrictedCashMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001884082psny:RestrictedCashMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001884082ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001884082ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:LiabilitiesToCreditInstitutionsMember2024-06-300001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:LiabilitiesToCreditInstitutionsMember2023-12-310001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:OtherNonCurrentInterestBearingLiabilitiesMember2024-06-300001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:OtherNonCurrentInterestBearingLiabilitiesMember2023-12-310001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:AccruedExpensesMember2024-06-300001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:AccruedExpensesMember2023-12-310001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:TradePayablesMember2024-06-300001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:TradePayablesMember2023-12-310001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:InterestBearingCurrentLiabilitiesAndInterestBearingCurrentLiabilitiesMember2024-06-300001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:InterestBearingCurrentLiabilitiesAndInterestBearingCurrentLiabilitiesMember2023-12-310001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:InterestBearingCurrentLiabilitiesRelatedPartiesMember2024-06-300001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:InterestBearingCurrentLiabilitiesRelatedPartiesMember2023-12-310001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:RepurchaseCommitmentsMember2024-06-300001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:RepurchaseCommitmentsMember2023-12-310001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:AdvancePaymentFromCustomersMember2024-06-300001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:AdvancePaymentFromCustomersMember2023-12-310001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:OtherCurrentLiabilitiesDueFromRelatedPartiesMember2024-06-300001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:OtherCurrentLiabilitiesDueFromRelatedPartiesMember2023-12-310001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:OtherNonCurrentLiabilitiesMember2024-06-300001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberpsny:OtherNonCurrentLiabilitiesMember2023-12-310001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember2024-06-300001884082ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember2023-12-310001884082ifrs-full:NotLaterThanOneYearMemberifrs-full:TradeReceivablesMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberifrs-full:TradeReceivablesMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberifrs-full:TradeReceivablesMember2024-06-300001884082ifrs-full:TradeReceivablesMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:AccruedIncomeDueFromRelatedPartiesMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:AccruedIncomeDueFromRelatedPartiesMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:AccruedIncomeDueFromRelatedPartiesMember2024-06-300001884082psny:AccruedIncomeDueFromRelatedPartiesMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:OtherCurrentReceivablesMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:OtherCurrentReceivablesMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:OtherCurrentReceivablesMember2024-06-300001884082psny:OtherCurrentReceivablesMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:OtherNonCurrentReceivablesMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:OtherNonCurrentReceivablesMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:OtherNonCurrentReceivablesMember2024-06-300001884082psny:OtherNonCurrentReceivablesMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:RestrictedCashMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:RestrictedCashMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:RestrictedCashMember2024-06-300001884082psny:RestrictedCashMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:LiabilitiesToCreditInstitutionsMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:LiabilitiesToCreditInstitutionsMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:LiabilitiesToCreditInstitutionsMember2024-06-300001884082psny:LiabilitiesToCreditInstitutionsMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:AccruedExpensesMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:AccruedExpensesMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:AccruedExpensesMember2024-06-300001884082psny:AccruedExpensesMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:TradePayablesMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:TradePayablesMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:TradePayablesMember2024-06-300001884082psny:TradePayablesMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:InterestBearingCurrentLiabilitiesAndInterestBearingCurrentLiabilitiesMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:InterestBearingCurrentLiabilitiesAndInterestBearingCurrentLiabilitiesMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:InterestBearingCurrentLiabilitiesAndInterestBearingCurrentLiabilitiesMember2024-06-300001884082psny:InterestBearingCurrentLiabilitiesAndInterestBearingCurrentLiabilitiesMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:RepurchaseCommitmentsMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:RepurchaseCommitmentsMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:RepurchaseCommitmentsMember2024-06-300001884082psny:RepurchaseCommitmentsMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:AdvancePaymentFromCustomersMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:AdvancePaymentFromCustomersMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:AdvancePaymentFromCustomersMember2024-06-300001884082psny:AdvancePaymentFromCustomersMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:OtherCurrentLiabilitiesDueFromRelatedPartiesMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:OtherCurrentLiabilitiesDueFromRelatedPartiesMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:OtherCurrentLiabilitiesDueFromRelatedPartiesMember2024-06-300001884082psny:OtherCurrentLiabilitiesDueFromRelatedPartiesMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:NonCurrentLiabilitiesToCreditInstitutionsMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:NonCurrentLiabilitiesToCreditInstitutionsMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:NonCurrentLiabilitiesToCreditInstitutionsMember2024-06-300001884082psny:NonCurrentLiabilitiesToCreditInstitutionsMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:OtherNonCurrentInterestBearingLiabilitiesMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:OtherNonCurrentInterestBearingLiabilitiesMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:OtherNonCurrentInterestBearingLiabilitiesMember2024-06-300001884082psny:OtherNonCurrentInterestBearingLiabilitiesMember2024-06-300001884082ifrs-full:NotLaterThanOneYearMemberpsny:OtherNonCurrentLiabilitiesMember2024-06-300001884082ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberpsny:OtherNonCurrentLiabilitiesMember2024-06-300001884082ifrs-full:LaterThanFiveYearsMemberpsny:OtherNonCurrentLiabilitiesMember2024-06-300001884082psny:OtherNonCurrentLiabilitiesMember2024-06-300001884082psny:ClassC1OrdinarySharesMember2024-06-300001884082psny:ClassC1OrdinarySharesMember2023-12-310001884082psny:ClassC2AmericanDepositarySharesMember2023-12-310001884082psny:ClassC1AndClassC2SharesMember2024-06-300001884082psny:ClassC1AndClassC2SharesMember2023-12-310001884082psny:ClassC1OrdinarySharesMember2024-01-012024-06-300001884082psny:ClassC1OrdinarySharesMember2023-01-012023-06-300001884082psny:ClassC2AmericanDepositarySharesMember2023-01-012023-06-300001884082psny:ClassCSharesMember2024-01-012024-06-300001884082psny:ClassCSharesMember2023-01-012023-06-300001884082psny:GoresGuggenheimIncBusinessCombinationAgreementBCAMember2023-01-012023-12-310001884082psny:GoresGuggenheimIncBusinessCombinationAgreementBCAMember2024-01-012024-06-300001884082psny:GoresGuggenheimIncBusinessCombinationAgreementBCAMember2023-01-012023-06-300001884082psny:ClassAOrdinarySharesMember2023-12-310001884082psny:ClassBAmericanDepositarySharesMember2023-12-310001884082psny:ClassAOrdinarySharesMember2024-01-012024-06-300001884082psny:ClassBAmericanDepositarySharesMember2024-01-012024-06-300001884082psny:ClassAOrdinarySharesMember2024-06-300001884082psny:ClassBAmericanDepositarySharesMember2024-06-300001884082psny:ClassAOrdinarySharesMemberpsny:PolestarAutomotiveHoldingUKPLCParentMember2024-06-300001884082psny:ClassAOrdinarySharesMemberifrs-full:RelatedPartiesMember2024-06-300001884082psny:ClassBAmericanDepositarySharesMemberpsny:PolestarAutomotiveHoldingUKPLCParentMemberifrs-full:RelatedPartiesMember2024-06-300001884082psny:ClassC1OrdinarySharesMemberpsny:PolestarAutomotiveHoldingUKPLCParentMember2024-06-300001884082psny:ClassC1OrdinarySharesMemberpsny:PolestarAutomotiveHoldingUKPLCParentMember2024-06-300001884082psny:ClassC2AmericanDepositarySharesMemberpsny:PolestarAutomotiveHoldingUKPLCParentMember2024-06-300001884082psny:ClassC2AmericanDepositarySharesMemberpsny:PolestarAutomotiveHoldingUKPLCParentMember2024-06-300001884082psny:RedeemablePreferredSharesMemberpsny:PolestarAutomotiveHoldingUKPLCParentMember2024-06-300001884082psny:ClassAOrdinarySharesMember2024-06-300001884082psny:ClassBAmericanDepositarySharesMember2024-06-300001884082psny:ClassCSharesMember2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:BorrowingsFromBanksMember2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:BorrowingsFromBanksMember2023-12-310001884082psny:CurrentLiabilitiesMemberpsny:FloorplanFacilitiesMember2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:FloorplanFacilitiesMember2023-12-310001884082psny:CurrentLiabilitiesMemberpsny:SaleLeasebackFacilitiesMember2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:SaleLeasebackFacilitiesMember2023-12-310001884082psny:CurrentLiabilitiesMember2024-06-300001884082psny:CurrentLiabilitiesMember2023-12-310001884082psny:NonCurrentLiabilitiesMemberpsny:SyndicatedLoanFromBanksMember2024-06-300001884082psny:NonCurrentLiabilitiesMemberpsny:SyndicatedLoanFromBanksMember2023-12-310001884082psny:NonCurrentLiabilitiesMember2024-06-300001884082psny:NonCurrentLiabilitiesMember2023-12-310001884082psny:LiabilitiesToCreditInstitutionsMember2024-06-300001884082psny:LiabilitiesToCreditInstitutionsMember2023-12-310001884082psny:CurrentLiabilitiesMemberpsny:SecuredOvernightFinancingRateMemberpsny:A3MonthSecuredOvernightFinancingRatePlus2.3Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:SecuredOvernightFinancingRateMemberpsny:A12MonthSecuredOvernightFinancingRatePlus0.9Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:SecuredOvernightFinancingRateMemberpsny:A12MonthSecuredOvernightFinancingRatePlus1.1Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:LoanPrimeRateMemberpsny:A12MonthLoanPrimeRatePlus0.25Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:SecuredOvernightFinancingRateMemberpsny:A12MonthSecuredOvernightFinancingRatePlus0.65Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:SecuredOvernightFinancingRateMemberpsny:A12MonthSecuredOvernightFinancingRatePlus1.11Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:LoanPrimeRateMemberpsny:A12MonthLoanPrimeRatePlus0.15Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:LoanPrimeRateMemberpsny:A12MonthLoanPrimeRatePlus1.05Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:SecuredOvernightFinancingRateMemberpsny:A12MonthSecuredOvernightFinancingRatePlus1.7Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:EuroInterbankOfferedRateMemberpsny:A3MonthEuroInterbankOfferedRate2.3Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:LoanPrimeRateMemberpsny:March12MonthLoanPrimeRatePlus1.05Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:LoanPrimeRateMemberpsny:April12MonthLoanPrimeRatePlus0.35Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:LoanPrimeRateMemberpsny:May12MonthLoanPrimeRatePlus0.35Member2024-06-300001884082psny:CurrentLiabilitiesMemberpsny:LoanPrimeRateMemberpsny:June12MonthLoanPrimeRatePlus0.85Member2024-06-300001884082psny:NonCurrentLiabilitiesMemberpsny:SyndicatedLoanFromBanksMembersrt:MinimumMember2024-06-300001884082psny:NonCurrentLiabilitiesMemberpsny:SecuredOvernightFinancingRateMemberpsny:A3MonthSecuredOvernightFinancingRatePlus3.35Member2024-06-300001884082psny:NonCurrentLiabilitiesMemberpsny:EuroInterbankOfferedRateMemberpsny:A3MonthEuroInterbankOfferedRate2.85Member2024-06-300001884082psny:NonCurrentLiabilitiesMemberpsny:SyndicatedLoanFromBanksMembersrt:MaximumMember2024-06-300001884082psny:FloorplanFacilitiesMember2024-06-300001884082psny:FloorplanFacilitiesMember2023-12-310001884082psny:FloorplanFacilitiesMemberifrs-full:RelatedPartiesMemberpsny:VolvoCarsMember2024-06-300001884082psny:FloorplanFacilitiesMemberifrs-full:RelatedPartiesMemberpsny:VolvoCarsMember2023-12-310001884082psny:FloorplanFacilitiesMemberifrs-full:RelatedPartiesMember2024-06-300001884082psny:VolvoCarsMemberifrs-full:RelatedPartiesMember2022-11-030001884082psny:SecuredOvernightFinancingRateMemberifrs-full:RelatedPartiesMemberpsny:VolvoCarsMember2022-11-030001884082psny:VolvoCarsMemberifrs-full:RelatedPartiesMember2023-11-080001884082psny:VolvoCarsMemberifrs-full:RelatedPartiesMember2024-06-300001884082psny:GeelyMemberifrs-full:RelatedPartiesMember2023-11-080001884082psny:GeelyMemberifrs-full:RelatedPartiesMember2024-06-300001884082psny:PolestarTimesTechnologyMemberifrs-full:RelatedPartiesMember2023-01-012023-06-300001884082psny:VolvoCarsMemberifrs-full:RelatedPartiesMember2024-01-012024-06-300001884082psny:VolvoCarsMemberifrs-full:RelatedPartiesMember2023-01-012023-06-300001884082psny:ZikloBankABMemberifrs-full:RelatedPartiesMember2024-01-012024-06-300001884082psny:ZikloBankABMemberifrs-full:RelatedPartiesMember2023-01-012023-06-300001884082psny:GeelyMemberifrs-full:RelatedPartiesMember2024-01-012024-06-300001884082psny:GeelyMemberifrs-full:RelatedPartiesMember2023-01-012023-06-300001884082ifrs-full:RelatedPartiesMember2024-01-012024-06-300001884082ifrs-full:RelatedPartiesMember2023-01-012023-06-300001884082psny:RenaultKoreaMotorsCo.LtdMemberifrs-full:RelatedPartiesMember2024-01-012024-06-300001884082psny:RenaultKoreaMotorsCo.LtdMemberifrs-full:RelatedPartiesMember2023-01-012023-06-300001884082psny:ZheijiangC2MDigitalTechnologyCo.LtdMemberifrs-full:RelatedPartiesMember2024-01-012024-06-300001884082psny:ZheijiangC2MDigitalTechnologyCo.LtdMemberifrs-full:RelatedPartiesMember2023-01-012023-06-300001884082psny:WuxiInfiMotionPropulsionTechnologyCo.Ltd.Memberifrs-full:RelatedPartiesMember2024-01-012024-06-300001884082psny:WuxiInfiMotionPropulsionTechnologyCo.Ltd.Memberifrs-full:RelatedPartiesMember2023-01-012023-06-300001884082ifrs-full:GrossCarryingAmountMemberpsny:AcquiredIntellectualPropertyMember2023-01-012023-12-310001884082psny:VolvoCarsMemberifrs-full:RelatedPartiesMember2023-12-310001884082psny:GeelyMemberifrs-full:RelatedPartiesMember2023-12-310001884082psny:ZikloBankABMemberifrs-full:RelatedPartiesMember2024-06-300001884082psny:ZikloBankABMemberifrs-full:RelatedPartiesMember2023-12-310001884082psny:VolvoCarFinancialServicesUKMemberifrs-full:RelatedPartiesMember2024-06-300001884082psny:VolvoCarFinancialServicesUKMemberifrs-full:RelatedPartiesMember2023-12-310001884082psny:PolestarTimesTechnologyMemberifrs-full:RelatedPartiesMember2024-06-300001884082psny:PolestarTimesTechnologyMemberifrs-full:RelatedPartiesMember2023-12-310001884082ifrs-full:RelatedPartiesMember2024-06-300001884082ifrs-full:RelatedPartiesMember2023-12-310001884082psny:WuhanLotusCarsCo.LTD.Memberifrs-full:RelatedPartiesMember2024-06-300001884082psny:WuhanLotusCarsCo.LTD.Memberifrs-full:RelatedPartiesMember2023-12-310001884082psny:BatteryVolumeCommitmentsPS2Member2024-06-300001884082psny:TransportationServicesMember2024-06-300001884082psny:ManufacturingCommitmentsPS3AndPS4Member2024-06-300001884082psny:LicenseVolumeCommitmentsPS4Member2024-06-300001884082psny:ContractualCommitmentsToAcquireAssetsAndIntangiblesMember2024-06-300001884082ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember2024-08-022024-08-020001884082ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember2024-08-020001884082psny:RevolvingCreditFacilitiesMemberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:StandardCharteredBankMember2024-08-200001884082psny:SecuredOvernightFinancingRateMemberpsny:A3MonthSecuredOvernightFinancingRatePlus1Memberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:StandardCharteredBankMember2024-08-200001884082psny:SecuredOvernightFinancingRateMemberpsny:A12MonthSecuredOvernightFinancingRatePlus1.2Memberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:StandardCharteredBankMember2024-08-200001884082psny:RevolvingCreditFacilitiesMemberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:StandardCharteredBankMember2024-08-230001884082psny:RevolvingCreditFacilitiesMemberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:StandardCharteredBankMember2024-09-090001884082psny:SecuredOvernightFinancingRateMemberpsny:A12MonthSecuredOvernightFinancingRatePlus1.2Memberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:StandardCharteredBankMember2024-08-230001884082psny:RevolvingCreditFacilitiesMemberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:BancoBilbaoVizcayaArgentariaS.A.Member2024-09-270001884082psny:SecuredOvernightFinancingRateMemberpsny:A12MonthSecuredOvernightFinancingRatePlus1Memberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:StandardCharteredBankMember2024-09-270001884082psny:RevolvingCreditFacilitiesMemberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:VolvoCarsMember2024-08-210001884082psny:RevolvingCreditFacilitiesMemberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:VolvoCarsMember2024-11-030001884082psny:RevolvingCreditFacilitiesMemberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:VolvoCarsMember2024-11-080001884082psny:SecuredOvernightFinancingRateMemberpsny:A6MonthSecuredOvernightFinancingRatePlus4.9Memberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:VolvoCarsMember2024-08-210001884082ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:WorkingCapitalLoanMember2024-08-272024-08-270001884082ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:WorkingCapitalLoanMember2024-08-270001884082ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:WorkingCapitalLoanMember2024-08-282024-08-280001884082ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:WorkingCapitalLoanMember2024-08-280001884082ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:BancoBilbaoVizcayaArgentariaS.A.Member2024-09-162024-09-160001884082psny:RevolvingCreditFacilitiesMemberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:BancoBilbaoVizcayaArgentariaS.A.Member2024-09-160001884082psny:RevolvingCreditFacilitiesMemberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:BancoBilbaoVizcayaArgentariaS.A.Member2024-09-190001884082psny:SecuredOvernightFinancingRateMemberpsny:A12MonthSecuredOvernightFinancingRatePlus1.10Memberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:BancoBilbaoVizcayaArgentariaS.A.Member2024-09-190001884082psny:RevolvingCreditFacilitiesMemberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:StandardCharteredBankMember2024-09-270001884082psny:SecuredOvernightFinancingRateMemberpsny:A1MonthSecuredOvernightFinancingRatePlus1.1Memberifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:BancoBilbaoVizcayaArgentariaS.A.Member2024-09-270001884082ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:WorkingCapitalLoanMember2024-09-192024-09-190001884082ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:WorkingCapitalLoanMember2024-09-190001884082ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:WorkingCapitalLoanMember2024-09-262024-09-260001884082ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMemberpsny:WorkingCapitalLoanMember2024-09-260001884082srt:ScenarioPreviouslyReportedMember2024-01-012024-06-300001884082srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2024-01-012024-06-300001884082psny:ClassASharesMembersrt:ScenarioPreviouslyReportedMember2024-01-012024-06-300001884082psny:ClassASharesMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2024-01-012024-06-300001884082psny:ClassBSharesMembersrt:ScenarioPreviouslyReportedMember2024-01-012024-06-300001884082psny:ClassBSharesMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2024-01-012024-06-300001884082srt:ScenarioPreviouslyReportedMember2024-06-300001884082srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2024-06-300001884082srt:ScenarioPreviouslyReportedMember2023-12-310001884082srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-12-310001884082srt:ScenarioPreviouslyReportedMember2023-01-012023-06-300001884082srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-01-012023-06-300001884082psny:RevisionOfPriorPeriodOriginallyRestatedMember2023-01-012023-06-300001884082psny:RevisionOfPriorPeriodAmendedFor6KMember2023-01-012023-06-300001884082psny:ClassASharesMembersrt:ScenarioPreviouslyReportedMember2023-01-012023-06-300001884082psny:ClassASharesMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-01-012023-06-300001884082psny:ClassASharesMemberpsny:RevisionOfPriorPeriodOriginallyRestatedMember2023-01-012023-06-300001884082psny:ClassASharesMemberpsny:RevisionOfPriorPeriodAmendedFor6KMember2023-01-012023-06-300001884082psny:ClassBSharesMembersrt:ScenarioPreviouslyReportedMember2023-01-012023-06-300001884082psny:ClassBSharesMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-01-012023-06-300001884082psny:ClassBSharesMemberpsny:RevisionOfPriorPeriodOriginallyRestatedMember2023-01-012023-06-300001884082psny:ClassBSharesMemberpsny:RevisionOfPriorPeriodAmendedFor6KMember2023-01-012023-06-300001884082srt:ScenarioPreviouslyReportedMember2022-12-310001884082srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2022-12-310001884082psny:RevisionOfPriorPeriodOriginallyRestatedMember2022-12-310001884082psny:RevisionOfPriorPeriodAmendedFor6KMember2022-12-310001884082srt:ScenarioPreviouslyReportedMember2023-06-300001884082srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-06-300001884082psny:RevisionOfPriorPeriodOriginallyRestatedMember2023-06-300001884082psny:RevisionOfPriorPeriodAmendedFor6KMember2023-06-30

Image_0.gif
Image_0.gif
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

Image_4.jpg


FORM 6-K/A

Image_4.jpg

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2025

Commission File Number: 001-41431

Image_7.jpg

Polestar Automotive Holding UK PLC

Image_7.jpg

Assar Gabrielssons Väg 9
405 31 Göteborg, Sweden
(Address of Principal Executive Office)

Image_7.jpg

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒    Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Image_3.jpg
Image_3.jpg
1

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

Attached as exhibits to this report on Form 6-K are (i) Polestar’s Management’s Discussion and Analysis of Financial Conditions and Results of Operations for Six months ended June 30, 2024 and 2023 which is attached as Exhibit 99.1; and (ii) Polestar’s Unaudited Condensed Consolidated Financial Statements as of June 30, 2024 and for the Six months ended June 30, 2024 and 2023, which are attached as Exhibit 99.2.



EXPLANATORY NOTE

Polestar Automotive Holding UK PLC (the “Company”) is filing this Amendment No. 1 on Form 6-K (this “Amendment” or “Form 6-K/A”) to amend the Report on Form 6-K originally filed by the Company with the Securities and Exchange Commission (the “SEC”) on September 30, 2024 (the “Original Report”). Specifically, this Amendment (i) amends and restates its Management’s Discussion and Analysis of Financial Conditions and Results of Operations for the six months ended June 30, 2024 and 2023 (the “Affected Interim Periods”) filed as Exhibit 99.1 to the Original Report, and (ii) amends and restates the Company’s previously issued unaudited condensed consolidated financial statements for the Affected Interim Periods filed as Exhibit 99.2 to the Original Report. The amended and restated Management’s Discussion and Analysis of Financial Conditions and Results of Operations and unaudited condensed consolidated financial statements sections for the Affected Interim Periods are included as Exhibit 99.1 and 99.2, respectively, to this Form 6-K/A.

The Company has restated certain information presented in its annual report on Form 20-F for the years ended December 31, 2022 and December 31, 2023 (“the Restated Financial Statements”) and made certain other changes to reflect the Restated Financial Statements, the effects of the Restated Financial Statements and related matters on Form 20-F/A filed with the SEC on April 23, 2025 (the "20-F/A"). Additionally, on May 9, 2025, the Company filed its Consolidated Financial Statements with the SEC as of December 31, 2024 and 2023 and for each of the years in the three-year period ended December 31, 2024 in its annual report on Form 20-F.

Investors and other readers should rely only on the financial information and other related disclosures regarding the six months ended June 30, 2023 and June 30, 2024 contained in this Form 6-K/A and should not rely on the Original Report nor any previously issued or filed reports, press releases, presentations or similar communications containing financial information or other related disclosures from the Original Report.

Restatement Background

As previously reported on the Company’s Current Report on Form 6-K filed on January 16, 2025, on January 14, 2025, the Company’s management, in consultation with the Audit Committee of the Board of Directors (the “Audit Committee”), concluded that the Company’s previously issued audited financial statements included within its annual reports on Form 20-F for the years ended December 31, 2022 and December 31, 2023 (the “Audited Affected Financials”) and the unaudited interim financial information included within Current Reports on Form 6-K for the interim periods ended on and falling between September 30, 2022 and June 30, 2024 (the “Unaudited Affected Financials” and together with the Audited Affected Financials, the “Affected Financials”) contain errors. The Audit Committee, based on the recommendation of, and after consultation with, the Company’s management, further concluded that the Affected Financials should no longer be relied upon.

The Company has restated the Audited Affected Financials with the 20-F/A, and is filing this Amendment now to restate the unaudited interim financial information for the six-month periods ended June 30, 2024 and 2023 included in the Original Report.

The primary reason for the previous restatement relates to balance sheet errors concerning the Company’s unique tooling (further explained below), which resulted in an underreporting of assets and accrued liabilities in matching amounts for the periods referenced above. The correction of these balance sheet errors has no impact on previously reported revenue, operating loss, net loss, adjusted EBITDA or net assets, nor do these corrections affect the Company’s underlying business operations, cash position, or liquidity.

As previously disclosed, the Company owns unique tooling which is used in the manufacturing of its vehicles. This unique tooling has previously been recognized as property plant and equipment once either the production standard part process test is conducted or production utilizing the unique vendor tools has occurred. Due to contractual terms, management determined that certain unique tooling should have instead been recognized as assets under construction (“AUC”) according to the progression of work, resulting in a material understatement of AUC and a corresponding understatement of accrued liabilities in the Affected Financials. The reconsideration of AUC recognition changed the timing of recognizing AUC but does not change the expected total amount of AUC recognized.

A reclassification of cash flows between operating and investing activities and other smaller errors that have been identified are also being corrected as part of this restatement process.

Refer to Note 18 - Restatement of prior period unaudited interim financial statements beginning on page F-27 of this Form 6-K/A for additional information.

Other than the restatement items listed above or discussed in Note 18 - Restatement of prior period unaudited interim financial statements, management has not incorporated retroactive changes for any disclosure updates that were included in filings subsequent to the submission of the Original Report on September 30, 2024.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
2


This Report on Form 6-K/A (including information incorporated by reference herein, this “Report”) includes statements that express Polestar’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements” as defined in Section 27A of the Securities Act, and Section 21E of the Exchange Act, that involve significant risks and uncertainties. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may,” “will” or “should” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this Report and include statements regarding Polestar’s intentions, beliefs or current expectations concerning, among other things: the benefits of the Business Combination; results of operations; financial condition; liquidity; prospects; growth; strategies and the markets in which Polestar operates, including estimates and forecasts of financial and operational metrics, projections of market opportunity, market share and vehicle sales; expectations and timing related to commercial product launches, including the start of production and launch of any future products of Polestar, and the performance, range, autonomous driving and other features of the vehicles of Polestar; future market opportunities, including with respect to energy storage systems and automotive partnerships; future manufacturing capabilities and facilities; future sales channels and strategies; and future market launches and expansion.

Such forward-looking statements are based on available current market information and the current expectations of Polestar including beliefs and forecasts concerning future developments and the potential effects of such developments on Polestar. There can be no assurance that future developments affecting Polestar will be those that Polestar has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond Polestar’s control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors” in Item 3.D in the annual report on Form 20-F for the year ended December 31, 2024, which was filed with the SEC on May 9, 2025. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Polestar will not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.



EXHIBIT INDEX

Exhibit No.Description of Exhibit
99.1
Management’s Discussion and Analysis of Financial Conditions and Results of Operations for the Six months ended June 30, 2024, and 2023.
99.2
Unaudited Condensed Consolidated Financial Statements as of June 30, 2024 and for the Six months ended June 30, 2024, and 2023.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

POLESTAR AUTOMOTIVE HOLDING UK PLC


Date: July 1, 2025     By:     /s/ Michael Lohscheller
Name: Michael Lohscheller
Title:     Chief Executive Officer


By:     /s/ Jean-François Mady
Name: Jean-François Mady
Title:     Chief Financial Officer


3

Management’s Discussion and Analysis of Financial Conditions and Results of Operations
The following discussion includes information that is relevant to understanding Polestar’s financial condition and results of operations and should be read together with the Unaudited Condensed Consolidated Financial Statements for the six months ended June 30, 2024 and 2023, included elsewhere in this report. Refer to the Consolidated Financial Statements for Polestar Automotive Holding UK PLC, as of December 31, 2023 and 2022, and for the three years ended December 31, 2023 that were included in the Form 20-F/A filed with the SEC on April 23, 2025 for more information about the year ended December 31, 2023. All figures presented in the tables below are in thousands of U.S. dollars unless otherwise stated. Additionally, certain figures for the six months ended June 30, 2023 and June 30, 2024 have been restated. Refer to Note 18 - Restatement of prior period unaudited interim financial statements for details.
As of and for the six months ended June 30,
Key metrics20242023
Global volumes1
20,37127,868
Volume of external vehicles without repurchase obligations18,48626,123
Volume of external vehicles with repurchase obligations9781,229
Volume of internal vehicles907516
Markets2
2727
Locations3
189150
Service points4
1,1631,129
1 - Represents the sum of total volume of vehicles delivered for (a) external sales of new vehicles without repurchase obligations, (b) external sales of vehicles with repurchase obligations, and (c) internal use vehicles for demonstration and commercial purposes or to be used by Polestar employees (vehicles are owned by Polestar and included in Inventories). A vehicle is deemed delivered and included in the volume figure for each category once invoiced and registered to the external or internal counterparty, irrespective of revenue recognition. Revenue is recognized in scenarios (a) and (b) in accordance with IFRS 15, Revenue from Contracts with Customers ("IFRS 15"), and IFRS 16, Leases ("IFRS 16"), respectively. Revenue is not recognized in scenario (c).
2 - Represents the markets in which Polestar operates.
3 - Represents Polestar Spaces, Polestar Destinations, and Polestar Test Drive Centers.
4 - Represents Volvo Cars service centers to provide access to customer service points worldwide in support of Polestar’s international expansion.
Key factors affecting performance
Polestar’s continued growth depends on numerous factors and trends. While these factors and trends provide opportunities for Polestar, they also pose risks and challenges as discussed in item 3.D “Risk Factors” in the Form 20-F filed with the SEC on May 9, 2025. The following paragraphs explain the key factors that had a notable impact on Polestar during the six months ended June 30, 2024.
Partnerships with Volvo Cars and Geely
Polestar’s relationship with Volvo Cars and Geely has provided it with a unique competitive advantage in its ability to rapidly scale and finance commercialization activities while maintaining an asset light balance sheet. This is achieved primarily through contract manufacturing, supply, and financing agreements with Volvo Cars and Geely. Polestar has utilized Volvo Cars' and Geely's established research and development capabilities to accelerate technological advancements in automotive technology. Additionally, selling and administrative expenses have been positively impacted due to service agreements with Volvo Cars which allow Polestar to attain operational efficiencies in the areas of aftermarket services and maintenance and back-office functions (e.g., information technology, legal, accounting, finance, and human resources).
Utilizing Volvo Cars’ and Geely's facilities has allowed Polestar to continue efficient production of its vehicles. Having access to the global manufacturing footprint of Volvo Cars and Geely has and will continue to provide Polestar with flexibility to adjust and optimize its manufacturing plans in response to factors like particular market demand, relative production cost, changing shipping and logistic expenses, and the availability of market-specific tax credit schemes. However, Polestar’s contract manufacturing model does not come with the operating leverage that may come with owning production facilities and requires Polestar to accurately forecast the demand for its vehicles. If Polestar fails to do so, there may be overcapacity, which may negatively impact gross margins, or inadequate capacity, which may result in delays in shipments or revenues.
As of June 30, 2024, Polestar had drawn on all $1,000 million in borrowing capacity entered into with Volvo Cars. This includes the $800 million term loan credit facility with Volvo Cars that was entered into on November 3, 2022 and an additional $200 million that was provided as extra borrowing capacity on November 8, 2023. Additionally, Polestar had drawn the entire $250 million term loan entered into with Geely on November 8, 2023. Both loans with Volvo Cars and Geely have a maturity date of June 30, 2027 and therefore as of June 30, 2024, all principal under both loans remains outstanding. Both loans have an optional equity conversion feature.
On December 8, 2023, Polestar and Geely entered into an asset transfer agreement which, when considered together with certain other agreements not signed until six months ended June 30, 2024, was designed to provide financing to Polestar in exchange for Polestar transferring legal ownership of certain Polestar unique tooling and equipment that will be used in the manufacturing of the PS3 (the "PS3 Tooling and Equipment") to Geely. As of June 30, 2024, total principal of $129.5 million was outstanding under this financing arrangement.
Refer to Note 15 - Related party transactions in the Unaudited Condensed Consolidated Financial Statements included elsewhere in this report for more information.
4

Premium electric vehicle portfolio
Polestar continues to develop a premium all-electric vehicle portfolio to address the tastes and preferences of premium vehicle customers, one of the fastest growing segments of the global electric car market. The planned portfolio currently consists of the following models:
•Polestar 2 - a performance fastback;
•Polestar 3 - a performance sport utility vehicle;
•Polestar 4 - a performance sport utility coupe;
•Polestar 5 - a high performance 4-door grand tourer; and
•Polestar 6 - a high performance roadster.
The PS2 has received numerous accolades and positive reviews since its launch in 2019. The limited-edition higher specification PS2 variants, the BST 270 and BST 230, which sell at higher price points have also received favorable reviews from customers and the automotive community. Polestar plans to continue offering higher specification variants, sometimes in limited production runs, for its future models, which it expects will further establish its brand within the premium electric vehicle segment and allow for pricing variability within certain markets. As a premium electric vehicle company, Polestar does not intend to offer models priced below the PS2. Customers’ acceptance and purchase of Polestar’s new models are critical components of Polestar’s future growth and financial performance. Polestar’s marketing efforts may not be successful, and newer vehicle models may not ultimately be adopted or utilized by the consumer, which would negatively impact sales volumes and product pricing.
Innovative automotive technologies and design
Polestar develops electric vehicles and technologies through cutting edge design and sustainable choices. Polestar has a high-performance, innovation-driven research and development team with safety heritage rooted from Volvo Cars and in-house competencies at its dedicated research and development facility in Coventry, UK. Internal development programs such as the Polestar 5 and PX2 electric powertrain have advanced Polestar’s organic intellectual property. Further, Polestar continues to display ambition to create industry-leading technologies through partnerships with Volvo Cars, Geely, Nvidia, Luminar, and Zenseact, Xingji Meizu, and StoreDot, among others. This combination of research and development resources allows Polestar flexibility in determining which technologies to develop in-house versus which to outsource to partners. Polestar believes that continued investments such as these are critical to establishing market share, attracting new customers, and becoming a profitable global electric vehicle company. During the six months ended June 30, 2024, Polestar invested $141.8 million in new intellectual property. Refer to Note 8 - Intangible assets and goodwill in the Unaudited Condensed Consolidated Financial Statements included elsewhere in this report for more information.
Direct-to-consumer business model
Polestar operates a direct-to-consumer business model for sales of vehicles, which allows it to create a tailored experience for customers based on their individual preferences. Polestar cultivates this experience through Polestar Spaces where potential customers can experience Polestar vehicles, engage with Polestar specialists, and in certain cases, test drive Polestar vehicles. This serves as important brand awareness and as a sales driver for commercial expansion in key markets. Through these locations, Polestar is able to introduce customers to vehicles and enhance the Polestar experience, from brand introduction and education to vehicle delivery. Additionally, Polestar is able to run a lean sales model via the Polestar App and website, offer a wide service network for aftermarket services and maintenance, and offer competitive pricing and financing for customers. This business model approach has allowed Polestar to achieve rapid expansion in, and capitalization of, the luxury electric vehicle market in Europe, the United States, and Asia with lower overall selling, general, and administrative expenses as compared to a traditional OEM dealer model.
Direct-to-business model
In the U.S. and Canada, Polestar operates a direct-to-business model through which vehicles are sold directly to a network of independent authorized dealers. In these markets, vehicles are displayed and subsequently sold to end retail consumers at Polestar Spaces, which are designed, built, and equipped by dealers in accordance with Polestar’s standards. Dealers also diagnose and repair Polestar vehicles at associated service facilities. Vehicles are sold to dealers at wholesale prices and Polestar provides a suggested retail price.
Fleet sales
In addition to Polestar and its subsidiaries’ direct-to-consumer and direct-to-business models, vehicles are also sold to various fleet customers (e.g., rental car companies and corporate fleet managers). As an incentive for high-volume purchases, sales to fleet customers often include certain upfront discounts and annual rebates based on the number of vehicles ordered during the year.
Importer markets
Polestar also sells vehicles to various importers in smaller markets around the globe where it does not have sales units (e.g., Hong Kong, New Zealand, Israel, the United Arab Emirates (UAE), Kuwait, and Iceland). Polestar's relationships with importers allow it to create a more diversified global footprint and tap potential opportunities which may lead to increased sales.
Sales to associate
In China, during the six months ended June 30, 2024, Polestar sold its vehicles through an associate, Polestar Times Technology (Nanjing) Co., Ltd ("Polestar Times Technology"), previously Polestar Technology (Shaoxing) Co., Ltd. ("Polestar Technology"). Vehicles were sold to Polestar Times Technology at whole sale prices and Polestar Times Technology subsequently sold the vehicles to customers in China.
Earn-out rights and Class C Shares from the reverse recapitalization
5

As part of a capital reorganization consummated on June 23, 2022, Polestar exchanged rights and obligations to the public and private warrant instruments of Gores Guggenheim, Inc. ("GGI"), a special purpose acquisition company, resulting in the issuance of similar instruments in the form of Class C-1 Shares and Class C-2 Shares, respectively. Polestar also issued certain rights to earn out shares to existing owners. These instruments are accounted for as derivative liabilities under International Accounting Standards (“IAS”) 32, Financial Instruments: Presentation, and IFRS 9, Financial Instruments, that are carried at fair value with subsequent changes in fair value recognized in the Consolidated Statement of Loss and Comprehensive Loss at each reporting date.
As of June 30, 2024 and December 31, 2023, the Class C Shares were valued at $3.5 million and $6.0 million, respectively, resulting in an unrealized gain from the fair-value change of $2.5 million during the six months ended June 30, 2024. As of June 30, 2024 and December 31, 2023, the earn-out rights were valued at $15.8 million and $155.4 million, respectively, resulting in an unrealized gain from the fair value change of $139.6 million during the six months ended June 30, 2024. The fair values of these derivative financial instruments are volatile and influenced by changes Polestar's share price, resulting in impacts to Polestar's net income or loss that are not directly related to ongoing operations. Nevertheless, these derivative financial instruments have a notable impact on our overall financial performance each period. Refer to Note 1 - Overview and basis of preparation and Note 11 - Reverse recapitalization in the Unaudited Condensed Consolidated Financial Statements included elsewhere in this report for more information.
Impacts of the Russo-Ukrainian War, conflicts in Israel and the Gaza Strip, and conflict in the Red Sea
While Polestar does not directly conduct any business with suppliers in Russia or the Ukraine, there can be no assurance that all parts of the supply chain are devoid of any exposure to disruptions caused by the Russo-Ukrainian War.
The conflict between Israel and Hamas and uncertain geopolitical conditions, sanctions, and other potential impacts on the global economic environment may weaken demand for Polestar’s vehicles and impact its ability to access production components, which could make it difficult for Polestar to forecast its financial results and manage its inventory levels. Israel is one of Polestar's importer markets where we have minimal sales. Polestar also has some suppliers with operations in Israel, including Mobileye and StoreDot. If the conditions in Israel interrupt Polestar’s suppliers’ operations or limit the ability for Polestar’s suppliers to operate, Polestar’s business can be harmed. Additionally, in the past, Israel and Israeli companies have been, and continue to be, subject to economic boycotts and divestment initiatives, which could negatively impact Polestar’s business given Polestar’s relationship with Mobileye and StoreDot.
In addition, further escalation of the conflict in the Red Sea may affect our shipping operations and result in shipping companies rerouting their cargo ships. These potential shipping disruptions may cause additional shipping costs and delays.
Refer to Item 3.D “Risk Factors” in Form 20-F/A filed with the SEC on April 23, 2025 for information on risks posed by the ongoing conflicts between Russia and Ukraine, in Israel and the Gaza Strip, and in the Red Sea.
Inflation
Global economic conditions have caused rising inflationary pressures on prices of components, materials, labor, and equipment used in the production of Polestar vehicles. Overall increases in the cost of components, materials, labor, and equipment are expected to lead to higher costs of goods sold in the future. Additionally, the natural time lag created by the production, shipping, and selling of vehicles has also contributed to a delay in price increases experienced by Polestar. Higher oil prices have, in the past, also increased freight and distribution costs across all markets. It is uncertain whether inflationary pressures will persist in the future. Polestar will continue to closely monitor the effects of the Russo-Ukrainian War, the conflicts in Israel and the Gaza Strip, and inflation on its business.
Additional key factors impacting performance
Polestar’s continued growth depends on numerous factors and trends, including continued sales of the PS2 and new sales of the PS4 at anticipated volumes while production and sales of the PS3 ramps-up. This includes the ramp-up of sales in the US market of these models, particularly the PS3, which is, in part, dependent on the successful ramp-up of production at the facility in Charleston, South Carolina operated by Volvo Cars. Polestar’s regional mix of sales, including higher sales in the US market, and its overall product mix, is important to maintain its gross margins. Ramping-up Polestar’s production at other facilities is also an important factor in the success of Polestar’s future vehicle production and delivery. In addition to increasing vehicle volume, Polestar is focused on developing additional revenue streams, such as IP licensing, aftermarket revenue, component sales, and/or used car sales. If Polestar’s vehicle sales and additional revenue streams do not develop as anticipated, Polestar may not have the necessary cash flow to operate its business and repay outstanding indebtedness. Furthermore, Polestar’s gross margins are dependent upon Polestar’s current pricing structure, which is subject to a variety of factors, including certain average selling price assumptions. If Polestar has higher than expected discounting or advertising and promotion costs, its future margins may suffer.
Polestar’s gross margins are also dependent upon its ability to manage costs, including costs associated with raw materials and key components of production, tariffs on imports from China, and to implement cost savings initiatives. Polestar’s future financial performance also requires Polestar to accurately forecast demand for its vehicles. Inaccurate demand forecasts may lead to Polestar offering deeper discounts or experiencing greater than expected sales volumes of discounted vehicles. As a result of inaccurate forecasts, Polestar could also experience higher than expected production, operating expense, advertising, sales and promotion costs or may be unable to effectively charge such costs to customers in a targeted manner. This could result in vehicles being sold with fewer options and trim levels, higher than expected sales volumes of lower-priced variants, and/or failure of Polestar to meet its gross margin and profitability expectations.
Results of operations
Polestar conducts business under one operating segment with primary commercial operations in North America, Europe, Asia, and various importer markets. Refer to Note 1 - Overview and basis of preparation in the Unaudited Condensed Consolidated Financial Statements included elsewhere in this report for more information on the basis of presentation. Refer to Note 2 - Significant accounting policies and judgements in the Consolidated Financial Statements for Polestar Automotive Holding UK PLC, as of December 31, 2023 and 2022,
6

and for the three years ended December 31, 2023 that were included the Form 20-F/A filed with the SEC on April 23, 2025 for more information related to segment reporting.
Comparison of the six months ended June 30, 2024, and 2023
The following table summarizes Polestar’s historical Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated) for six months ended June 30, 2024, and 2023.
For the six months ended June 30,Variance
20242023$%
(Restated)(Restated)
Revenue909,247 1,236,365 (327,118)(26)
Cost of sales(932,533)(1,214,750)282,217 (23)
Gross profit/(loss)$(23,286)$21,615 $(44,901)(208)
Selling, general and administrative expense(450,465)(474,607)24,142 (5)
Research and development expense(24,312)(83,050)58,738 (71)
Other operating income, net21,913 38,559 (16,646)(43)
Operating loss$(476,150)$(497,483)$21,333 (4)
Finance income8,077 12,489 (4,412)(35)
Finance expense(199,278)(94,963)(104,315)110 
Fair value change - Earn-out rights139,638 232,995 (93,357)(40)
Fair value change - Class C Shares2,500 10,750 (8,250)(77)
Share of losses in associates$(4,350)$— $(4,350)— 
Loss before income taxes$(529,563)$(336,212)$(193,351)58 
Income tax expense(14,315)(5,331)(8,984)169 
Net loss$(543,878)$(341,543)$(202,335)59 
Revenues
Polestar’s net Revenue for the six months ended June 30, 2024 was $909.2 million, a decrease of $327.2 million, or 26% compared to $1,236.4 million for the six months ended June 30, 2023. Revenue from related parties for the six months ended June 30, 2024 was $160.7 million, an increase of $83.7 million, or 109% compared to $77.0 million for the six months ended June 30, 2023.
The following table summarizes the components of revenue and related changes between interim periods:
For the six months ended June 30,Variance
20242023$%
(Restated)(Restated)
Revenues
Sales of vehicles888,652 1,208,791 (320,139)(26)
Sales of software and performance engineered kits7,891 11,419 (3,528)(31)
Sales of carbon credits40 532 (492)(92)
Vehicle leasing revenue11,566 7,493 4,073 54 
Other revenue1,098 8,130 (7,032)(86)
Total$909,247 $1,236,365 $(327,118)(26)
Sales of vehicles for the six months ended June 30, 2024 were $888.7 million, a decrease of $320.1 million, or 26% compared to $1,208.8 million for the six months ended June 30, 2023. The decrease was driven primarily by lower volumes of Polestar 2 sales across certain geographic markets such as the United Kingdom, United States, Germany, and Sweden. Additionally, a $106.7 million increase in discounts to fleet customers contributed to the decrease in revenue from Sales of vehicles.
Sales of software and performance engineered kits for the six months ended June 30, 2024 were $7.9 million, a decrease of $3.5 million, or 31% compared to $11.4 million for the six months ended June 30, 2023. The decrease is a result of Polestar's continued emphasis on its own vehicles, coupled with a continued decline in Volvo Car's sales of Polestar's performance engineered kits.
Vehicle leasing revenue for the six months ended June 30, 2024 was $11.6 million, an increase of $4.1 million, or 54% compared to $7.5 million for the six months ended June 30, 2023. This activity is primarily driven by greater recognition of deferred revenue for repurchase vehicles sold to external parties as compared to the six months ended June 30, 2023.
7

Other revenue for the six months ended June 30, 2024 was $1.1 million, a decrease of $7.0 million, or 86% compared to $8.1 million for the six months ended June 30, 2023. The decrease is driven primarily by less sales-based royalties received from Volvo Cars on sales of parts and accessories for the Polestar as compared to the six months ended June 30, 2023.
Cost of sales and gross profit/(loss)
Cost of sales for the six months ended June 30, 2024 was $932.5 million, a decrease of $282.3 million, or 23% compared to $1,214.8 million for the six months ended June 30, 2023. This decrease was mainly due to a $199.5 million reduction in material costs related to lower sales volumes of Polestar 2, an $88.7 million reversal of previous inventory impairments for vehicles sold, and decreased warranty costs of $17.6 million. These decreases were partially offset by an increase in write-downs of inventories to net realizable value of $19.9 million.
Gross profit/(loss) for the six months ended June 30, 2024 was a gross loss of $23.3 million, a decrease of $44.9 million, or 208% compared to a gross profit of $21.6 million for the six months ended June 30, 2023. This decrease is attributed to lower net revenue of $327.1 million primarily due to lower volumes of Polestar 2 sales and greater dealer discounts. Refer to the explanation of the Revenue variances above for greater details. These negative impacts were partially offset by a $199.5 million reduction in material cost and a $88.7 million reversal of previous inventory impairments for vehicles sold.
Selling, general, and administrative expense
Selling, general, and administrative expense for the six months ended June 30, 2024 was $450.5 million, a decrease of $24.1 million, or 5% compared to $474.6 million for the six months ended June 30, 2023. This activity is primarily due to a decrease in media activities expense of $22.2 million.
Research and development expense
Research and development expense for the six months ended June 30, 2024 was $24.3 million, a decrease of $58.8 million, or 71%, from $83.1 million for the six months ended June 30, 2023. This change was primarily driven by a decrease in the amortization costs as Polestar 2 intellectual property began capitalization into inventory during the fourth quarter of the year ended December 31, 2023. Until then, the Polestar 2 intellectual property was amortized into Research and development expense. Additionally, Polestar 6 reached the capitalization phase during the second half of the year ended December 31, 2023, and therefore costs related to the development of the Polestar 6 are no longer recognized in Research and development expense.
Other operating income, net
Other operating income, net for the six months ended June 30, 2024 was an income of $21.9 million, a decrease of $16.7 million, or 43% compared to an income of $38.6 million for the six months ended June 30, 2023. This decrease is primarily driven by higher negative foreign exchange effects on working capital comprised of realized and unrealized gains on foreign currency transactions of $40.6 million. Additional decreases were attributed to increased other operating expenses of $5.8 million. These decreases were partially offset by $29.4 million of income, mostly related to income recognized during the six months ended June 30, 2024 for services provided to Polestar Times Technology during the year ended December 31, 2023.
Finance income
Finance income for the six months ended June 30, 2024 was $8.1 million, a decrease of $4.4 million, or 35% compared to $12.5 million for the six months ended June 30, 2023. This decrease was primarily the result of lower interest income on bank accounts of $7.2 million. This decrease was partially offset by an increase in other finance income due to the modification of the loan related to the sale of PS3 tooling to a related party of $2.5 million.
Finance expense
Finance expense for the six months ended June 30, 2024 was $199.3 million, an increase of $104.3 million, or 110% compared to $95.0 million for the six months ended June 30, 2023. This increase was primarily the result of higher interest expense due to related parties of $45.3 million, higher interest expense associated with liabilities to credit institutions of $38.7 million, and higher negative realized and unrealized foreign exchange effects of $17.4 million.
Fair value change - Earn-out rights
The gain on Fair value change - Earn-out rights for the six months ended June 30, 2024 was $139.6 million, a decrease of $93.4 million, or 40% compared to $233.0 million for the six months ended June 30, 2023. This change is primarily attributable to a decrease in Polestar's share price and a comparable change in Polestar’s share price during the six months ended June 30, 2024, as compared to the six months ended June 30, 2023. The share price changed by $1.47, from $2.26 to $0.79 for the six months ended June 30, 2024, compared to $1.49, from $5.31 to $3.82 for the six months ended June 30, 2023. Leveraging a benchmark of peers and utilizing historical data, the implied equity volatility used in the Monte Carlo simulation is 80% as of June 30, 2024, as compared to 75% as of June 30, 2023.
Fair value change - Class C Shares
The gain on the fair value change of these warrants (i.e, Class C Shares) for the six months ended June 30, 2024 was $2.5 million, a decrease of $8.3 million or 77% compared to $10.8 million for the six months ended June 30, 2023. This decrease is primarily attributable to a smaller change in the price of the Class C-1 Shares and the estimated value of the Class C-2 Shares by $0.10, from $0.24 to $0.14 for the six months ended June 30, 2024, compared to $0.43, from $
8

1.12 to $0.69 for the six months ended June 30, 2023.
Polestar utilizes a binomial lattice model to calculate the value of the Class C-2 Shares which factors several inputs, including the changes in Polestar’s share price, the implied volatility of Class C-1 Shares, and risk-free rate. During the six months ended June 30, 2024, Polestar's share price decreased by $1.47, from $2.26 to $0.79, implied volatility of publicly traded Class C-1 Shares increased from 88% to 225%, and risk-free rate increased from 3.93% to 4.47% over the same period. During the six months ended June 30, 2023 Polestar's share price decreased by $1.49, from $5.31 to $3.82, implied volatility of publicly traded Class C-1 Shares increased from 89% to 94%, and risk-free rate increased from 4.01% to 4.27% over the same period.
Share of earnings in associate
During the six months ended June 30, 2024, Polestar injected cash of $34.3 million into Polestar Times Technology and maintained 46.2% ownership. Polestar recognized an expense of $4.4 million for the six months ended June 30, 2024, this expense is attributed to Polestar's share of Polestar Times Technology's net losses. As Polestar completed its First Contribution Condition in Polestar Technology on December 20, 2023, there is no comparable period. Polestar's carrying value of its investment in Polestar Technology was zero as a result of its share of Polestar Technology's losses.
Liquidity and capital resources
Polestar continues to finances its operations primarily through various short-term credit facilities, including working capital facilities, medium term loans with credit institutions and related parties, sale leaseback arrangements, inventory finance facilities and extended trade credit with related parties. Polestar anticipates it will continue to need to raise funding via these methods and via equity to meet the cash requirements to fulfill its obligations. The principal uses for liquidity and capital are funding operations, repayment of debt, market expansion, and investments in Polestar's future vehicles and automotive technologies.
Polestar continues to generate negative operating and investing cash flows as a result of scaling up commercialization efforts globally, along with continuing capital expenditures for the PS2, PS3, PS4, PS5, and PS6. Managing the company’s liquidity profile and funding needs remains one of management’s key priorities. Substantial doubt about Polestar's ability to continue as a going concern persists as timely realization of financing endeavors is necessary to cover forecasted operating and investing cash outflow. Refer to Note 1 - Overview and basis of preparation in the accompanying Unaudited Condensed Consolidated Financial Statements included elsewhere in this report for more information.
Polestar intends to continue developing its short, medium, and long-term financing relationships with European and Chinese banking partners and Polestar's related parties, including upsizing current facilities where applicable, while also continuing to explore potential equity or debt offerings.
Debt financing
Polestar enters into various debt arrangements with European and Chinese banking partners, related parties, and other financial institutions in the form of short-term, medium-term, and long-term funding to meet Polestar's capital needs.
Current and non-current Liabilities to credit institutions
During the periods presented in the accompanying Unaudited Condensed Consolidated Financial Statements, Polestar utilized several short-term working capital loans, primarily originating from European and Chinese banking partners. These existing and developing relationships provide Polestar with a reliable source of short-term liquidity. All short-term working capital loans that have come due during the periods presented have been repaid on-time. Short-term working capital loans are primarily used for the purposes of achieving sales volumes. Current Liabilities to credit institutions are in the form of loans from banks, floor plan facilities, and sale leaseback facilities.
On February 22, 2024, Polestar entered into its first non-current loan agreement with credit institutions. This was in the form of a syndicated multicurrency green trade facility with 12 banks including Standard Chartered Bank acting as agent and security agent. The facility consists of two tranches: Facility A (EUR denominated at €336.1 million with an interest rate at the relevant EURIBOR plus 2.85%) and Facility B (USD denominated at $576.6 million, with an interest rate at the Chicago Mercantile Exchange Term SOFR plus 3.35%). Both facilities have a 36-month repayment period with repayment of utilizations due in full at the end of the period, including any unpaid interest and other fees. The facilities are secured by interest reserve accounts pledges with an aggregate of three months interest deposited upon utilization of available credit. As of June 30, 2024, Polestar had fully utilized its borrowing capacity and drawn down on $936.2 million.
This syndicated loan is subject to covenant requirements, including but not limited to a minimum annual revenue of $5,359.9 million for 2024, minimum quarterly cash levels of €400 million, and maximum quarterly financial indebtedness of $5,500 million.
Polestar's green trade facility entered into on February 28, 2022 is subject to certain covenant requirements and shares the same minimum quarterly cash covenant as the syndicated loan.
As of June 30, 2024, Polestar had total Current liabilities to credit institutions and Non-current liabilities to credit institutions outstanding of $1,539.3 million and $936.2 million, respectively. Refer to Note 14 - Liabilities to credit institutions for information on Polestar's working capital loans outstanding as of June 30, 2024.
Comparison of the six months ended June 30, 2024 and 2023
As of June 30, 2024, Polestar had Cash and cash equivalents of $668.9 million as compared to $768.3 million as of December 31, 2023. Cash and cash equivalents consist of cash in banks with an original term of three months or less. As of June 30, 2024, the Group had restricted cash of $21.5 million which is presented within Other non-current assets in the Unaudited Condensed
9

Consolidated Statement of Financial Position (as restated). As of December 31, 2023, the Group had restricted cash of $1.8 million which is presented as Other non-current assets in the Unaudited Condensed Consolidated Statement of Financial Position (as restated). The following table summarizes Polestar’s Unaudited Condensed Consolidated Statement of Cash Flows (as restated) for the six months ended June 30, 2024 and 2023:
For the six months ended June 30,Variance
20242023$
(Restated)(Restated)
Cash used for operating activities(267,671)(666,746)399,075 
Cash used for investing activities(272,689)(279,168)6,479 
Cash provided by financing activities461,391 1,067,857 (606,466)
Cash used for operating activities
Cash used for operating activities for the six months ended June 30, 2024 was $267.7 million, a decrease of $399.0 million compared to $666.7 million for the six months ended June 30, 2023. The change is primarily attributable to positive changes in working capital during the six months ended June 30, 2024.
Cash provided by changes in inventories for the six months ended June 30, 2024 was a cash inflow of $160.8 million, an increase of $350.0 million compared to cash outflow of $189.2 million for the six months ended June 30, 2023. This change is primarily due to greater vehicle sales relative to vehicles produced for the six months ended June 30, 2024 compared to the six months ended June 30, 2023.
Cash provided by changes in trade receivables, prepaid expenses, and other assets for the six months ended June 30, 2024 was a cash inflow of $98.6 million, an increase of $38.3 million compared to a cash inflow of $60.3 million for the six months ended June 30, 2023.This change is primarily due to a $45.2 million decrease in Trade receivables from related parties, reflecting higher collections from Volvo Cars in the six months ended June 30, 2024 compared to the six months ended June 30, 2023.
Cash used for trade payables, accrued expenses, and other liabilities for the six months ended June 30, 2024 was a cash outflow of $3.2 million, a decrease of $135.5 million compared to a cash outflow of $138.7 million for the six months ended June 30, 2023. This change is primarily due to $231.2 million in lower settlements of trade payables to Volvo Cars for the six months ended June 30, 2024 compared to the six months ended June 30, 2023.
Cash provided by contract liabilities for the six months ended June 30, 2024 was a cash inflow of $24.2 million, a decrease of $2.8 million compared to a cash inflow of $27.0 million for the six months ended June 30, 2023. This is primarily due to lower volumes of Polestar 2 sales.
Cash used to pay interest for the six months ended June 30, 2024 was $146.2 million, an increase of $97.5 million compared to $48.7 million for the six months ended June 30, 2023. The change is primarily due to $89.1 million in higher interest paid to credit institutions related to working capital loans for the six months ended June 30, 2024 compared to the six months ended June 30, 2023.
Cash used for investing activities
Cash used for investing activities for the six months ended June 30, 2024 was $272.7 million, an increase of $6.5 million compared to $279.2 million for the six months ended June 30, 2023. The change is primarily related to a $41.0 million increase in Additions to property, plant, and equipment, an increase of $34.3 million due to the capital injection into Polestar Times Technology, and an increase of $21.5 million in restricted deposits related to the syndicated multicurrency green trade facility covenant requiring Polestar to keep cash restricted, equivalent to the interest expense of the current interest period for the six months ended June 30, 2024. These increases were offset by a decrease in Additions to intangible assets of $104.9 million for the six months ended June 30, 2024.
Cash provided by financing activities
Cash provided by financing activities for the six months ended June 30, 2024 was $461.4 million, a decrease of $606.5 million compared to $1,067.9 million for the six months ended June 30, 2023. The change was primarily the result of decreased liquidity provided by draw-downs on short-term working capital facilities with Chinese and European banking partners coupled with increased principal repayments on maturing loans during the six months ended June 30, 2024. Polestar’s borrowings provided $1,341.2 million in gross cash proceeds during the period, of which $952.8 million was sourced from a syndicated multicurrency green trade facility, $134.1 million was sourced from short-term working capital facilities with Chinese banking partners, $143.2 million was sourced from a green trade revolving credit facility with a syndicate of European banks, and $111.1 million was sourced from multiple low-value floorplan and sale-leaseback facilities, including the facility with Volvo Cars. These gross cash proceeds were partially offset by principal repayments of $867.2 million during the period, of which $212.5 million was used to settle short-term working capital facilities with Chinese banking partners, $553.5 million was used to settle amounts due on the green trade revolving credit facility, and $101.3 million was used to settle amounts due on the low-value floorplan and sale-leaseback facilities, including the facility with Volvo Cars. Additionally, $12.5 million was used to settle amounts due on lease liabilities.
Contractual obligations and commitments
Polestar is party to contractual obligations to make payments to third parties and related parties in the form of short-term credit facilities, sale leaseback arrangements, and various other leasing arrangements. Polestar also has certain capital commitments to purchase property, plant and equipment and intellectual property.
10


The following table summarizes Polestar’s estimated future cash expenditures related to contractual obligations and commitments as of June 30, 2024. All figures presented in the table below are in thousands of U.S. dollars unless otherwise stated. Additionally, certain figures have been restated. The capital and minimum purchase amounts presented within the following table decreased as a result of Management determining that certain previously disclosed contracts contained cancellation terms indicating the Company had no contractual commitment upon signing. Refer to Note 18 - Restatement of prior period unaudited interim financial statements for details of restatement of other Contractual obligations and commitments.
Payments due by period
Contractual obligations and commitmentsTotalLess than
1 year		Between
1-5 years		After 5
years
Capital commitments1
131,981 131,981 — — 
Minimum purchase commitments2
438,205 157,842 258,181 22,182 
Credit facilities, including sale leasebacks and floor plans3
2,486,620 1,539,331 947,289 — 
Other liabilities, including floor plans - related parties4
1,863,787 193,562 1,632,147 38,078 
Lease obligations including related parties5
121,210 34,990 74,185 12,035 
Total$5,041,803 $2,057,706 $2,911,802 $72,295 
1.Capital commitments relate to Polestar's investment in PPE and intangible assets for the production of upcoming PS3 models, PS4, PS5 and PS6. Additionally, the remaining capital injections Polestar will provide Polestar Times Technology are included herein.
2.Minimum purchase commitments relate to contracts with certain suppliers including a non-cancellable commitment, an agreed minimum purchase volume, or an agreed minimum sales volume. In the event of a shortfall in purchases, a shortfall in sales, or Polestar´s decision to terminate such contracts, these suppliers are entitled to compensation from Polestar. These amounts reflect Polestar's minimum payment obligation under these contracts.
3.Refer to Note 14 - Liabilities to credit institutions for further details on Polestar's credit facilities including sale leasebacks and floor plans.
4.Refer to Note 15 - Related party transactions for further details.
5.Refer to Note 6 - Leases for further details.
Off-balance sheet arrangements
Other than the capital commitments mentioned in “Contractual obligations and commitments” in this Form 6-K/A, Polestar does not maintain any off-balance sheet activities, arrangements, or relationships with unconsolidated entities (e.g., special purpose vehicles and structured finance entities) or persons that have a material current effect, or are reasonably likely to have a material future effect, on Polestar’s Consolidated Financial Statements.
Non-GAAP Financial Measures
Polestar uses both generally accepted accounting principles (“GAAP,” i.e., IFRS) and non-GAAP (i.e., non-IFRS) financial measures to evaluate operating performance, internal comparisons to historical performance, and other strategic and financial decision-making purposes. Polestar believes non-GAAP financial measures are helpful to investors as they provide useful perspective on underlying business trends and assist in period-on-period comparisons. These measures also improve the ability of management and investors to assess and compare the financial performance and position of Polestar with those of other companies.
These non-GAAP measures are presented for supplemental information purposes only and should not be considered a substitute for financial information presented in accordance with GAAP. The measures are not presented under a comprehensive set of accounting rules and, therefore, should only be read in conjunction with financial information reported under GAAP when understanding Polestar's operating performance.
The measures may not be the same as similarly titled measures used by other companies due to possible differences in calculation methods and items or events being adjusted. A reconciliation between non-GAAP financial measures and the most comparable GAAP performance measures is provided below.
Non-GAAP financial measures include adjusted EBITDA, adjusted net loss, and adjusted free cash flow.
Adjusted EBITDA
Adjusted EBITDA is calculated as Net loss, adjusted for Fair value change - Earn-out rights, Fair value change - Class C Shares, interest income, interest expense, Income tax expense, and depreciation and amortization expense. Adjusted EBITDA is defined as EBITDA, adjusted for certain income and expenses which are significant in nature and that management considers not reflective of ongoing operational activities. This measure is reviewed by management and is a relevant measure for understanding the underlying operating results and trends of the business prior to the impact of any adjusting items.
Adjusted Net Loss
Adjusted net loss is calculated as Net loss, adjusted to exclude Fair value change - Earn-out rights, Fair value change - Class C Shares. This measure represents Net loss, adjusted for certain income and expenses which are significant in nature and that management considers not reflective of ongoing operational activities. This measure is reviewed by management and is a relevant measure for understanding the underlying performance of Polestar's core business operations.
Adjusted Free Cash Flow
11

Adjusted free cash flow is calculated as Cash used for operating activities, adjusted to exclude cash flows used for property, plant and equipment and intangible assets. This measure is reviewed by management and is a relevant measure for understanding cash sourced from operating activities that is available to repay debts, fund capital expenditures, and spend on other strategic initiatives.
Reconciliation of GAAP and Non-GAAP Results
All figures presented in the tables below are in thousands of U.S. dollars unless otherwise stated. Additionally, certain figures for the six months ended June 30, 2023 and June 30, 2024 have been restated. Refer to Note 18 - Restatement of prior period unaudited interim financial statements for details.
Adjusted EBITDA
For the six months ended June 30,
20242023
(Restated)(Restated)
Net loss(543,878)(341,543)
Fair value change - Earn-out rights(139,638)(232,995)
Fair value change - Class C Shares(2,500)(10,750)
Interest income(5,606)(12,489)
Interest expense163,06576,176
Income tax expense14,3155,331
Depreciation and amortization expense22,76953,204
Adjusted EBITDA$(491,473)$(463,066)
Adjusted Net Loss
For the six months ended June 30,
20242023
(Restated)(Restated)
Net loss(543,878)(341,543)
Fair value change - Earn-out rights(139,638)(232,995)
Fair value change - Class C Shares(2,500)(10,750)
Adjusted net loss$(686,016)$(585,288)
Adjusted Free Cash Flow 
For the six months ended June 30,
20242023
(Restated)(Restated)
Net cash used for operating activities(267,671)(666,746)
Additions to property, plant and equipment(83,884)(42,948)
Additions to intangible assets(133,049)(237,930)
Adjusted free cash flow$(484,604)$(947,624)
Critical accounting estimates
Polestar did not have any new accounting estimates applied during the six months ended June 30, 2024 that are critical to the portrayal of our financial condition and results of operations and that require significant, difficult, subjective, or complex judgements. See Form 20-F/A filed with the SEC on April 23, 2025, for critical accounting estimates for the year ended December 31, 2023.
12




The Polestar Group
Unaudited Condensed Consolidated Financial Statements as of June 30, 2024 and for
the Six months ended June 30, 2024 and 2023


F-1

INDEX TO FINANCIAL STATEMENTS
Polestar Automotive Holding UK PLC
Unaudited Condensed Consolidated Financial Statements — For the Six months ended June 30, 2024 and 2023
Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated) for the Six months ended June 30, 2024 and 2023
F-3
Unaudited Condensed Consolidated Statement of Financial Position (as restated) as of June 30, 2024 and December 31, 2023
F-4
Unaudited Condensed Consolidated Statement of Changes in Equity (as restated) for the Six months ended June 30, 2024 and 2023
F-6
Unaudited Condensed Consolidated Statement of Cash Flows (as restated) for the Six months ended June 30, 2024 and 2023
F-7
Notes to Unaudited Condensed Consolidated Financial Statements (as restated)
F-8

F-2

Polestar Automotive Holding UK PLC
Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated)
(in thousands of U.S. dollars except per share data and unless otherwise stated)

Consolidated Statement of LossFor the six months ended June 30,
Note20242023
(Restated)1
(Restated)1
Revenue3909,247 1,236,365 
Cost of sales(932,533)(1,214,750)
Gross profit/(loss)(23,286)21,615 
Selling, general, and administrative expense(450,465)(474,607)
Research and development expense(24,312)(83,050)
Other operating income, net21,913 38,559 
Operating loss(476,150)(497,483)
Finance income8,077 12,489 
Finance expense(199,278)(94,963)
Fair value change - Earn-out rights11139,638 232,995 
Fair value change - Class C Shares112,500 10,750 
Share of losses in associates5(4,350)— 
Loss before income taxes(529,563)(336,212)
Income tax expense(14,315)(5,331)
Net loss(543,878)(341,543)
Net loss per share (in U.S. dollars)7
Class A - Basic and Diluted(0.26)(0.16)
Class B - Basic and Diluted(0.26)(0.16)
Consolidated Statement of Comprehensive Loss
Net loss(543,878)(341,543)
Other comprehensive loss:
Items that may be subsequently reclassified to the Consolidated Statement of Loss:
Exchange rate differences from translation of foreign operations(23,807)(27,502)
Total other comprehensive loss(23,807)(27,502)
Total comprehensive loss(567,685)(369,045)
1 - Refer to Note 18 - Restatement of prior period unaudited interim financial statements for reconciliations between originally reported and as revised amounts.

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
F-3

Polestar Automotive Holding UK PLC
Unaudited Condensed Consolidated Statement of Financial Position (as restated)
(in thousands of U.S. dollars unless otherwise stated)

NoteJune 30, 2024December 31, 2023
(Restated)1
Assets
Non-current assets
Intangible assets and goodwill81,465,902 1,418,707 
Property, plant, and equipment6, 9556,869 476,039 
Vehicles under operating leases669,512 70,223 
Other non-current assets1027,581 9,733 
Deferred tax asset37,058 42,336 
Other investments102,285 2,414 
Total non-current assets2,159,207 2,019,452 
Current assets
Cash and cash equivalents10668,911 768,264 
Trade receivables10146,334 126,716 
Trade receivables - related parties10, 1538,242 61,026 
Accrued income - related parties10, 1534,135 152,605 
Inventories12714,029 927,686 
Current tax assets14,261 12,657 
Other current assets10226,706 214,228 
Other current assets - related parties10, 152,904 9,576 
Total current assets1,845,522 2,272,758 
Total assets4,004,729 4,292,210 
Equity
Share capital(21,169)(21,168)
Other contributed capital(3,621,961)(3,615,187)
Foreign currency translation reserve49,446 25,639 
Accumulated deficit5,405,585 4,861,707 
Total equity131,811,901 1,250,991 
Liabilities
Non-current liabilities
Non-current contract liabilities3(59,651)(63,153)
Deferred tax liabilities(3,530)(3,335)
Other non-current provisions(97,798)(103,608)
Other non-current liabilities10(51,896)(127,423)
Earn-out liability10, 11(15,764)(155,402)
Non-current liabilities to credit institutions10, 14(936,217)— 
Other non-current interest-bearing liabilities6, 10(43,248)(54,439)
Other non-current interest-bearing liabilities - related parties15(1,400,095)(1,413,257)
Total non-current liabilities(2,608,199)(1,920,617)
Current liabilities
Trade payables10(80,967)(92,441)
Trade payables - related parties10, 15(404,233)(275,704)
Accrued expenses - related parties10, 15(198,970)(446,038)
Advance payments from customers10(18,694)(16,415)
Current provisions(85,493)(88,745)
Current liabilities to credit institutions10, 14(1,539,331)(2,026,665)
Current tax liabilities(6,152)(11,363)
Interest-bearing current liabilities6, 10(16,857)(19,547)
Interest-bearing current liabilities - related parties10, 15(89,970)(73,814)
Current contract liabilities3(51,093)(74,879)
Class C Shares liability10, 11(3,500)(6,000)
Other current liabilities10(691,044)(489,747)
Other current liabilities - related parties10, 15(22,127)(1,226)
Total current liabilities(3,208,431)(3,622,584)
F-4

Total liabilities(5,816,630)(5,543,201)
Total equity and liabilities(4,004,729)(4,292,210)
1 - Refer to Note 18 - Restatement of prior period unaudited interim financial statements for reconciliations between originally reported and as revised amounts.

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
F-5

Polestar Automotive Holding UK PLC
Unaudited Condensed Consolidated Statement of Changes in Equity (as restated)
(in thousands of U.S. dollars unless otherwise stated)

NoteShare capitalOther contributed capitalCurrency translation reserve
Accumulated deficit		Total
Balance as of January 1, 2023 (21,165)(3,584,232)15,496 3,679,832 89,931 
Net loss - (Restated)— — — 341,543 341,543 
Other comprehensive loss - (Restated)— — 27,502 — 27,502 
Total comprehensive loss - (Restated)— — 27,502 341,543 369,045 
Equity-settled share-based payment(2)(2,656)— — (2,658)
Balance as of June 30, 2023 - (Restated)(21,167)(3,586,888)42,998 4,021,375 456,318 
Balance as of January 1, 2024(21,168)(3,615,187)25,639 4,861,707 1,250,991 
Net loss - (Restated)— — — 543,878 543,878 
Other comprehensive loss - (Restated)— — 23,807 — 23,807 
Total comprehensive loss - (Restated)— — 23,807 543,878 567,685 
Equity-settled share-based payment - (Restated)(1)(6,774)— — (6,775)
Balance as of June 30, 2024 - (Restated)(21,169)(3,621,961)49,446 5,405,585 1,811,901 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
F-6

Polestar Automotive Holding UK PLC
Unaudited Condensed Consolidated Statement of Cash Flows (as restated)
(in thousands of U.S. dollars unless otherwise stated)

For the six months ended June 30,
Note20242023
(Restated)(Restated)
Cash flows from operating activities
Net loss(543,878)(341,543)
Adjustments to reconcile net loss to net cash flows:
Depreciation and amortization expense6, 8, 922,769 53,204 
Warranty provisions8,697 34,616 
Impairment of inventory1231,682 11,795 
Finance income(8,077)(12,489)
Finance expense199,278 94,963 
Fair value change - Earn-out rights11(139,638)(232,995)
Fair value change - Class C Shares11(2,500)(10,750)
Income tax expense14,315 5,331 
Share of losses in associates54,350 — 
Loss on derecognition and disposal of property, plant, and equipment and intangible assets— 2,070 
Litigation provisions2,784 — 
Other provisions15,826 14,873 
Unrealized exchange gain on trade payables(5,629)(5,022)
Other non-cash expense and income7,627 7,397 
Change in operating assets and liabilities:
Inventories160,813 (189,201)
Contract liabilities24,204 26,955 
Trade receivables, prepaid expenses, and other assets98,623 60,334 
Trade payables, accrued expenses, and other liabilities(3,196)(138,705)
Interest received5,606 12,489 
Interest paid(146,199)(48,667)
Taxes paid(15,128)(11,401)
Cash used for operating activities(267,671)(666,746)
Cash flows from investing activities
Additions to property, plant, and equipment9(83,884)(42,948)
Additions to intangible assets8(133,049)(237,930)
Additions to investment in associates5(34,300)— 
Additions to other non-current assets(21,490)— 
Proceeds from sale of property, plant, and equipment34 1,710 
Cash used for investing activities(272,689)(279,168)
Cash flows from financing activities
Change in restricted deposits— — 
Proceeds from short-term borrowings388,420 1,678,381 
Proceeds from long-term borrowings952,754 — 
Repayments of borrowings(867,249)(598,953)
Repayments of lease liabilities(12,534)(11,571)
Cash provided by financing activities461,391 1,067,857 
Effect of foreign exchange rate changes on cash and cash equivalents(20,384)(38,408)
Net (decrease) increase in cash and cash equivalents(99,353)83,535
Cash and cash equivalents at the beginning of the period768,264973,877
Cash and cash equivalents at the end of the period668,911 1,057,412
1 - Refer to Note 18 - Restatement of prior period unaudited interim financial statements for reconciliations between originally reported and as revised amounts.

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
F-7
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)

F-8
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Note 1 - Overview and basis of preparation
General information
Polestar Automotive Holding UK PLC (the “Parent”), together with its subsidiaries, hereafter referred to as “Polestar," “Polestar Group,” and the “Group," is a limited company incorporated in the United Kingdom. Polestar Group operates principally in the automotive industry, engaging in research and development, branding and marketing, and the commercialization and selling of battery electric vehicles, and related technology solutions. Polestar Group's current lineup of battery electric vehicles consists of the Polestar 2 ("PS2"), a premium fast-back sedan, the Polestar 3 ("PS3"), a luxury aero sport-utility vehicle, the Polestar 4 ("PS4"), a premium sport utility vehicle, the Polestar 5 ("PS5"), a luxury sport grand-touring sedan, and the Polestar 6 ("PS6"), a luxury roadster. As of June 30, 2024, the PS2, PS3, and PS4 are in production while the remaining vehicles are under development. Operating sustainably is a critical priority of the Group; targeting climate neutrality by 2040, creating a climate neutral car (cradle-to-gate) by 2030, and halving the emission intensity per car sold by 2030. Polestar Group has a presence in 27 markets across Europe, North America, and Asia. Polestar Group has its management headquarters located at Assar Gabrielssons väg 9, 41878 Göteborg, Sweden.
As of June 30, 2024, related parties owned 81.8% of the Group. The remaining 18.2% of the Group was owned by external investors. As of December 31, 2023, related parties owned 88.3% of the Group. The remaining 11.7% of the Group was owned by external investors.
Basis of preparation
The Unaudited Condensed Consolidated Financial Statements in this interim report of Polestar Group are prepared in accordance with International Accounting Standard 34, Interim Financial Reporting (“IAS 34”), as adopted by the International Accounting Standards Board (“IASB”) and UK-adopted international accounting standards. The Unaudited Condensed Consolidated Financial Statements have been prepared on the historical cost basis, except for the revaluation of certain financial instruments that are measured at fair values at the end of each reporting period, as explained in the accounting policies below. For group financial reporting purposes, Polestar Group companies apply the same accounting principles, irrespective of national legislation, as defined in the Group accounting directives. Such accounting principals have been applied consistently for all periods, unless otherwise stated.
This interim report is prepared in the presentation currency, U.S. Dollar (“USD”). All amounts are stated in thousands of USD (“TUSD”), unless otherwise stated.
Periods discussed prior to June 23, 2022 represent the operations of Polestar Automotive Holding Limited and its consolidated subsidiaries.
Going concern
Polestar Group’s Unaudited Condensed Consolidated Financial Statements have been prepared on a basis that assumes Polestar Group will continue as a going concern and the ordinary course of business will continue in alignment with management’s 2024-2028 business plan.
Management assessed Polestar Group’s ability to continue as a going concern and evaluated whether there are certain events or conditions, considered in the aggregate, that may cast substantial doubt about Polestar’s ability to continue as a going concern. All information available to management, including cash flow forecasts, liquidity forecasts, and internal risk assessments, pertaining to the twelve-month period after the issuance date of these Unaudited Condensed Consolidated Financial Statements was used in performing this assessment.
As a result of scaling up commercialization and continued capital expenditures related to the PS2, PS3, PS4, PS5, and PS6, managing the Company’s liquidity profile and funding needs remains one of management’s key priorities. If Polestar is not able to raise the necessary funds through operations, equity raises, debt financing, or other means, the Group may be required to delay, limit, reduce, or, in the worst case, terminate research and development and commercialization efforts. Since inception, Polestar Group has generated recurring net losses and negative operating and investing cash flows. Net losses for the six months ended June 30, 2024 and 2023 amounted to $543,878 and $341,543, respectively. Negative operating and investing cash flows for the six months ended June 30, 2024 and 2023 amounted to $540,360 and $945,914, respectively. Management’s 2024-2028 business plan indicates that Polestar will generate negative operating cash flows in the near future and positive operating cash flows starting the second half of 2025; investing cash flows of Polestar will continue to be negative in the near and long-term future due to the nature of Polestar’s business. Securing financing to support operating and development activities represents an ongoing challenge for Polestar Group.
Polestar Group primarily finances its operations through short-term working capital loan arrangements with credit institutions (i.e., 12 months or less), contributions from shareholders, extended trade credit from related parties, and long-term financing arrangements with related parties. Management’s 2024-2028 business plan indicates that Polestar Group depends on additional financing that is expected to be funded via a combination of new short-term working capital loan arrangements, long-term loan arrangements, shareholder loans with related parties, and executing capital market transactions through offerings of debt and/or equity. The timely realization of these financing endeavors is crucial for Polestar Group’s ability to continue as a going concern. If Polestar is unable to obtain financing from these sources or if such financing is not sufficient to cover forecasted operating and investing cash flow needs, Polestar Group will need to seek additional funding through other means (e.g., issuing new shares of equity or issuing bonds). Management has no certainty that Polestar Group will be successful in securing the funds necessary to continue operating and development activities as planned.
During the six months ended June 30, 2024, Polestar demonstrated efforts towards achieving liquidity targets in management's 2024-2028 business plan by:
•Securing long-term financing support from credit institutions; and
•Entering into multiple short-term working capital loan arrangements with banking partners in China.
F-9
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Polestar is party to financing instruments during the 12 months following the reporting period that contain financial covenants with which Polestar must comply. A failure to comply with such covenants may result in an event of default that could have material adverse effects on the business. Due to the factors discussed above, there is material uncertainty as to whether Polestar will be able to comply with all covenants in future periods. Remedies to an event of default include proactively applying for a covenant waiver prior to such event of default occurring.
Based on these circumstances, management reasonably expects there to be sufficient liquidity in the twelve-month period after the issuance date of these Unaudited Condensed Consolidated Financial Statements in order for Polestar to meet its cash flow requirements, but there is substantial doubt about Polestar’s ability to continue as a going concern. There are ongoing efforts in place to mitigate the uncertainty. The Unaudited Condensed Consolidated Financial Statements do not include any adjustments to factor for the going concern uncertainty.
Note 2 - Significant accounting policies and judgements
Adoption of new and revised standards
Effects of new and amended IFRS
Management has concluded the adoption of new standards and amendments effective from January 1, 2024 did not have a material impact on the Group’s Unaudited Condensed Consolidated Financial Statements. For a detailed assessment of the Group’s adoption of new and revised standards, refer to Note 2 - Significant accounting policies and judgements of the Consolidated Financial Statements for Polestar Automotive Holding UK PLC, as of December 31, 2023 and 2022, and for the three years ended December 31, 2023 that were included in the Form 20-F/A filed with the United States Securities and Exchange Commission (“SEC”) on April 23, 2025.
New and amended IFRS issued by not yet effective
Management has concluded the adoption of any of the below accounting pronouncements, that were issued but not effective during the six months ended June 30, 2024, will not have a material impact on the Group’s financial statements, unless otherwise noted.
In April 2024, the IASB issued IFRS 18, Presentation and Disclosure in Financial Statements ("IFRS 18"), which outlines the requirements for the presentation and disclosure of information in financial statements. It includes the requirement to classify income and expenses into three new categories: operating, investing, and financing. IFRS 18 will replace IAS 1 and will be effective for annual periods beginning on or after January 1, 2027.
In May 2024, the IASB issued IFRS 19, Subsidiaries without Public Accountability: Disclosures ("IFRS 19"), which specifies reduced disclosure requirements that eligible entities can apply instead of the disclosure requirements in other IFRS accounting standards. This standard for annual periods is effective beginning on or after January 1, 2027.
In May 2024, the IASB issued amendments to IFRS 7, Financial Instruments: Disclosures ("IFRS 7"), and IFRS 9, Financial Instruments ("IFRS 9"), which clarify certain elements of recognition, derecognition, classification, measurement, and disclosure of financial instruments. The amendments are effective for annual periods beginning on or after January 1, 2026.
Presentation, basis of consolidation, segment reporting, and foreign currency
For a detailed description of the Group’s presentation, basis of consolidation, segment reporting, and foreign currency, including currency risk, refer to Note 2 - Significant accounting policies and judgements and Note 3 - Financial risk management of the Consolidated Financial Statements for Polestar Automotive Holding UK PLC, as of December 31, 2023 and 2022, and for the three years ended December 31, 2023, that were included in the Form 20-F/A filed with the SEC on April 23, 2025. There are no changes for the periods presented in these Unaudited Condensed Consolidated Financial Statements.
Restatement
Current Restatement
In connection with the preparation of our consolidated financial statements as of and for the year ended December 31, 2024, management identified misstatements pertaining to the Unaudited Condensed Consolidated Financial Statements for the six months ended June 30, 2024 and 2023. The errors identified during 2024 relate to balance sheet errors concerning the Company's unique tooling, a reclassification of cash flows between operating and investing activities and other smaller errors that were corrected as part of the restatement process.
Prior Restatement included in the withdrawn 6-K filed on September 30, 2024 ("Prior Restatement")
The comparative disclosures in the Unaudited Condensed Consolidated Financial Statements for the six months ended June 30, 2023 were previously restated to align its presentation with the revisions during 2023 and correct for the carryforward impacts of the misstatements in our previously issued 2021 and 2022 annual financial statements. The prior period errors relate primarily to (i) accounting for inventories, including the accounting treatment of certain launch costs, capitalizable expenses into inventory and valuation adjustments for internal use cars, (ii) accounting for accruals and deferrals, (iii) capitalization of expenses, (iv) other errors relating to reclassifications between financial statement captions and (v) deferred taxes and income taxes.
The accompanying notes to the Unaudited Condensed Consolidated Financial Statements reflect the impact of these revisions. Refer to Note 18 - Restatement of prior period unaudited interim financial statements for reconciliations between originally reported and as revised interim amounts.
Accounting policies and use of estimates and judgements
Polestar Group continues to apply the same accounting policies, methods, estimates, and judgements as described in Note 2 - Significant accounting policies and judgements of the Consolidated Financial Statements for Polestar Automotive Holding UK PLC, as of December 31, 2023 and 2022, and for the three year
F-10
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
s ended December 31, 2023, that were included in the Form 20-F/A filed with the SEC on April 23, 2025. Management reviews its estimates and judgements on a continuous basis; changes in accounting estimates are recognized in the period in which the estimates are revised, and prospectively thereafter. Actual results could differ materially from those estimates using different assumptions or under different conditions. The Group did not have any events or new instruments requiring the application of new critical estimates and judgements during the six months ended June 30, 2024. However, the latest inputs to existing instruments requiring critical estimates and judgements utilized by the Group during the six months ended June 30, 2024 are detailed below. Additions to the Group's accounting policies and methods due to new events that occurred during the six months ended June 30, 2024 are included below as well.
Earnings per share
Basic earnings per share is calculated by dividing the net loss for the period by the weighted average number of Class A Shares and Class B Shares outstanding during the period. Diluted earnings per share is calculated by adjusting the net income for the period and the weighted average number of Class A Shares and Class B Shares outstanding for the effect of dilutive potential ordinary shares (“POSs”) outstanding during the period (i.e., Class A Shares and/or Class B Shares that the Group is obligated to issue, or might issue under certain circumstances, in accordance with various contractual arrangements). The Group’s POSs are classified based on the nature of their instrument or arrangement and then the earnings per incremental share (“EPIS”) is calculated for each class of POS to determine if they are dilutive or anti-dilutive. Anti-dilutive POSs are excluded from the calculation of dilutive earnings per share.
EPIS is calculated as (1) the consequential effect on profit or loss from the assumed conversion of the class of POS (i.e., the numerator adjustment) divided by (2) the weighted average number of outstanding POSs for the class (i.e., the denominator adjustment). The EPIS denominator adjustment depends on the class of POS. The Group’s classes of POSs and their related EPIS denominator adjustment methods are as follows:
POS ClassEPIS Denominator Adjustment Method
Unvested equity-settled RSUs and RSAs1
Treasury share2
Class C SharesTreasury share
Earn-out Rights and PSUsThe number of shares issuable if the reporting date were the end of the contingency period
Convertible Credit Facilities with Volvo Cars and Geely
If the instrument is converted, the number of shares issued on the
date of the conversion
1 - Restricted Stock Awards ("RSAs") are related to the Group's employee stock purchase plan implemented in January 2024.
2 - The treasury share method prescribed by IAS 33, Earnings Per Share (“IAS 33”), includes only the bonus element as the EPIS denominator adjustment. The bonus element is the difference between the number of ordinary shares that would be issued at the exercise of the options and the number of ordinary shares deemed to be repurchased at the average market price.
Financial instruments
Trade receivables factoring
In situations where Polestar Group enters into an arrangement to sell trade receivables to a third party (i.e., a factor) at a discount, the sale is accounted for in accordance with IFRS 9, Financial Instruments ("IFRS 9"). Polestar Group evaluates whether these transactions are with or without recourse and applies the derecognition criteria in IFRS 9 to determine if substantially all the risks and rewards of the trade receivables have been transferred to the factor.
For arrangements without recourse, where substantially all risks and rewards have been transferred in exchange for cash, the trade receivables are derecognized. For arrangements with recourse, where substantially all risks and rewards have not been transferred, the trade receivables are not derecognized, and the cash received from the purchaser is accounted for as secured borrowing.
Cash flows from factoring without recourse of trade receivables are classified as cash flows from operating activities in the Unaudited Condensed Consolidated Statement of Cash Flows (as restated) while cash flows from factoring with recourse are classified as cash flows from financing activities.
Fair value measurement
Valuation methodology for the fair value of the financial liability related to the Class C-2 Shares
The Class C-2 Shares represents a derivative financial instrument that is carried at fair value through profit and loss (“FVTPL”) by reference to Level 2 measurement inputs because an observable price for the Class C-1 Shares, which are almost identical instruments, is available in the active market. Class C Shares are presented in current liabilities within the Unaudited Condensed Consolidated Statement of Financial Position (as restated) as they can be exercised by the holder at any time. The related liability is measured at fair value, with any changes in fair value recognized in earnings. The fair value of the Class C-2 Shares is determined using a binomial lattice option pricing model in a risk-neutral framework whereby the future prices of the Class A Shares are calculated assuming a geometric Brownian motion (“GBM”). For each future price, the Class C-2 payoff amount is calculated based on the contractual terms of the Class C-2 Shares, including assumptions for optimal early exercise and redemption, and then discounted at the term-matched risk-free rate. The final fair value of the Class C-2 Shares is calculated as the probability-weighted present value over all modeled future payoff amounts. As of June 30, 2024, the fair value of the Class C-2 Shares was determined to equal $630 by leveraging the closing price of the Class C-1 Shares on the Nasdaq of $0.79 per share, an implied volatility of 225%, a risk-free rate of 4.47%, a dividend yield of 0%, and a 1,000 time-steps for the binomial lattice option pricing model. Refer to Note 11 - Reverse recapitalization for more detail on the Class C-2 Shares.
Valuation methodology for the fair value of the financial liability related to the Former Parent’s contingent earn-out rights
F-11
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
The Former Parent’s contingent earn out right represents a derivative financial instrument that is carried at FVTPL by reference to Level 3 measurement inputs because a quoted or observable price for the instrument or an identical instrument is not available in active markets. The earn-out liability is presented in non-current liabilities within the Unaudited Condensed Consolidated Statement of Financial Position (as restated) to align with the expected timing of the underlying earn-out payments. The fair value of the earn out is determined using a Monte Carlo simulation that incorporates a remaining term of 3.48 years, the five earn-out tranches, and the probability of the Class A Shares in the Parent reaching certain daily volume weighted average prices during the earn-out period resulting in the issuance of each tranche of Class A Shares and Class B Shares in the Parent to the Former Parent. As of June 30, 2024, the fair value of the earn-out was determined to equal $15,764 by leveraging an implied volatility of 80% and a risk-free rate of 4.43%. The implied volatility represents the most significant unobservable input utilized in this Level 3 valuation technique. The calculated fair value would increase (decrease) if the implied volatility were higher (lower). Refer to Note 11 - Reverse recapitalization for more detail on the Former Parent’s earn-out rights.
Note 3 - Revenue
Polestar Group disaggregates revenue by major category based on the primary economic factors that may impact the nature, amount, timing, and uncertainty of revenue and cash flows from these customer contracts as seen in the table below:
For the six months ended June 30,
20242023
(Restated)(Restated)
Sales of vehicles1
888,652 1,208,791 
Sales of software and performance engineered kits7,891 11,419 
Sales of carbon credits40 532 
Vehicle leasing revenue11,566 7,493 
Other revenue1,098 8,130 
Total$909,247 $1,236,365 
1 - Revenue related to sale of vehicles are inclusive of extended and connected services recognized over time.
For the six months ended June 30, 2024 and 2023, other revenue primarily consisted of license revenue generated from sales-based royalties received from Volvo Cars on sales of parts and accessories for Polestar vehicles, software performance upgrades and sale of technology to other related parties.
For the six months ended June 30, 2024 no sole customer, that is not a related party, exceeded 10% of total revenue. For the six months ended June 30, 2023, the Group’s largest customer that is not a related party accounted for $271,246 (22%) of revenue. Refer to Note 15—Related party transactions for further details on revenues from related parties.
Refund liabilities
For the six months ended June 30, 2024 and 2023, the Group reduced revenue by $98,991 and $51,633 for amounts related to variable consideration due to customers or service providers incentivizing contracts with customers, primarily in the form of volume related bonuses or discounts, residual value guarantees, and interest rate subvention schemes.
Contract liabilities
Deferred revenue - extended serviceDeferred revenue - connected serviceDeferred revenue - operating leases & otherTotal
Balance as of January 1, 202447,505 39,565 50,962 138,032 
Provided for during the period - (Restated)13,529 4,687 4,212 22,428 
Released during the period(12,821)(3,049)(29,445)(45,315)
Translation differences and other(1,316)(2,117)(968)(4,401)
Balance as of June 30, 2024 - (Restated)$46,897 $39,086 $24,761 $110,744 
of which current - (Restated)21,673 6,389 23,031 51,093 
of which non-current - (Restated)25,224 32,697 1,730 59,651 
As of June 30, 2024, contract liabilities amounted to $110,744, which was related to remaining performance obligations associated with sales of vehicles and vehicle leasing revenue.
Note 4 - Geographic information
Presentation, basis of consolidation, segment reporting, and foreign currency
F-12
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
For a detailed description of the Group’s presentation, basis of consolidation, segment reporting, and foreign currency, including currency risk, refer to Note 2 - Significant accounting policies and judgements and Note 3 - Financial risk management of the Consolidated Financial Statements for Polestar Automotive Holding UK PLC, as of December 31, 2023 that were included in the Form 20-F/A filed with the SEC on April 23, 2025. There are no changes for the periods presented in these Unaudited Condensed Consolidated Financial Statements.
The following tables show the breakdown of the Group’s revenue from external customers and non-current assets by geographical location where the Polestar company recognizing the revenue is located:
For the six months ended June 30,
Revenue20242023
(Restated)(Restated)
United Kingdom143,916 286,812 
Sweden139,768 168,146 
USA131,380 225,002 
Germany77,297 118,961 
China66,469 19,848 
Norway56,162 32,024 
Belgium46,981 47,490 
Netherlands42,456 50,171 
Canada41,399 62,130 
Denmark41,172 27,836 
Australia36,786 48,163 
Korea13,908 19,469 
Switzerland12,973 19,290 
Finland12,656 24,184 
Italy4,118 28,051 
Other regions1
41,806 58,788 
Total$909,247 $1,236,365 
1 - Revenue: Other regions primarily consist of Spain, Austria, and Luxembourg in June 2024.Other regions primarily consist of Austria, Spain and Ireland in 2023.
As of June 30, 2024As of December, 31, 2023
(Restated)
Non-current assets2
Sweden1,397,053 1,305,295 
China574,643 549,531 
United Kingdom36,439 32,342 
Germany34,275 27,058 
USA4,965 5,017 
Other regions3
44,908 45,726 
Total$2,092,283 $1,964,969 
2 - Non-current assets: excludes financial assets, Deferred tax assets, Other non-current assets, and Other investments.
3 - Other regions primarily consist of Belgium, Australia, and Switzerland in June 2024 and Switzerland, Australia, Belgium, and Spain in 2023.
Note 5 - Investment in associates
In January 2024, Polestar's investee in China, Polestar Technology (Shaoxing) Co., Ltd. ("Polestar Technology"), selected Nanjing as its final province of registration. The investee was renamed Polestar Times Technology (Nanjing) Co., Ltd ("Polestar Times Technology"). On February 29, 2024, Polestar Times Technology, Polestar, Xingji Meizu, and Nanjing Jiangning Economic and Technological Development Zone Industrial Equity Investment Partnership (the "Nanjing Investor") entered an agreement for Polestar Times Technology to receive an additional $60,360 in capital from the Nanjing Investor over four installments in exchange for equity; subject to Polestar Times Technology achieving certain increased paid-in capital and invoiced sales thresholds in Nanjing province. Additionally, Polestar Times Technology can receive an additional $148,298 in the form of capital reserves from the Nanjing Investor over the four installments. In the event Polestar Times Technology achieves these thresholds and secures the investment installments from the Nanjing Investor, Polestar's ownership in Polestar Times Technology will decrease from 49% to 37.6% over time. As of the date these Unaudited Condensed Consolidated Financial Statements were authorized for issuance, Polestar has injected total cash of $34,300 into Polestar Times Technology and maintains 46.2% ownership.
F-13
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
In the event of the dissolution of Polestar Times Technology and if Polestar Times Technology's assets are insufficient to meet its debt obligations, shareholders who have not fully made their required capital contributions and other shareholders existing at the time of establishment of the company, may be held jointly responsible for the remaining debts, limited to the value of their unpaid contributions.
Sales of vehicles
During the six months ended June 30, 2024, the probability of collecting consideration in exchange for vehicles sold to Polestar Times Technology remained remote due to Polestar Times Technology's lack of available liquidity. While Polestar did collect consideration from Polestar Times Technology during the six months ended June 30, 2024 for certain vehicles sold during the year ended December 31, 2023 and the six months ended June 30, 2024, the circumstances regarding Polestar Times Technology's liquidity have not been improved. As such, the Group's accounting for sales of vehicles to Polestar Times Technology remained unchanged from the year ended December 31, 2023. During the six months ended June 30, 2024, the Group collected consideration and recognized revenue related to sales of vehicles for $61,650 of which $31,298 pertained to vehicles delivered during the year ended December 31, 2023 and $30,352 pertained to vehicles delivered during the six months ended June 30, 2024. As of June 30, 2024, the Group remains unpaid for 542 vehicles delivered to Polestar Times Technology during the six months ended June 30, 2024; totaling $19,850 of unrecognized revenue.
The following table summarizes the activity related to Polestar's investment in Polestar Times Technology:
Balance as of January 1, 2024— 
Investment in Polestar Times Technology4,900 
Elimination of effects of downstream sales(550)
Recognized share of losses in Polestar Times Technology(4,350)
Balance as of June 30, 2024$— 
The following table summarizes the activity related to Polestar's unrecognized losses in Polestar Times Technology:
Unrecognized balance as of January 1, 2024(1,407)
Unrecognized effects of downstream sales(6,386)
Unrecognized share of losses in Polestar Times Technology(29,231)
Unrecognized balance as of June 30, 2024$(37,024)
The following table provides summarized financial information from Polestar Times Technology's financial statements and a reconciliation to the carrying amount of Polestar's investment:
For the six months ended June 30,
2024
Polestar's percentage ownership interest46.2 %
Non-current assets44,759 
Current assets60,806 
Non-current liabilities(21,379)
Current liabilities(132,663)
Net liabilities$(48,477)
Less capital reserves(29,492)
Adjusted Net liabilities$(77,969)
The Group's share of net liabilities(36,021)
Elimination of effects of downstream sales(550)
Unrecognized effects of downstream sales6,386 
Unrecognized losses in Polestar Times Technology29,231 
Other reconciling items954 
Carrying amount of the Group's investment in Polestar Times Technology$— 
Revenue44,490 
Net loss(70,851)
Other comprehensive loss(1,836)
Total comprehensive loss(72,687)
The Group's share of losses in Polestar Times Technology$(33,581)
F-14
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Note 6 - Leases
Polestar Group as Lessee
As a lessee, Polestar Group primarily leases buildings and manufacturing production equipment. The Group also has short-term and low value leases related to the leasing of temporary spaces and small IT equipment, respectively. The lease term for land and buildings is generally 2-15 years with the exception of one long term land lease with a term of 50 years. The lease term for machinery and equipment is generally 2-6 years.
The following table depicts the changes in the Group’s right-of-use assets, which are included within Property, plant, and equipment:

Buildings and land		Machinery and equipmentTotal
Acquisition cost
Balance as of January 1, 2024122,613 49,832 172,445 
Addition4,768 3,446 8,214 
Cancellations(10,858)(1,282)(12,140)
Remeasurement— (288)(288)
Effect of foreign currency exchange differences(4,063)(1,082)(5,145)
Balance as of June 30, 2024 - (Restated)$112,460 $50,626 163,086 
Accumulated depreciation
Balance as of January 1, 2024(34,291)(39,152)(73,443)
Depreciation expense(11,420)(1,815)(13,235)
Depreciation expense capitalized to inventory— (316)(316)
Cancellations2,913 1,068 3,981 
Effect of foreign currency exchange differences1,319 141 1,460 
Balance as of June 30, 2024- (Restated)$(41,479)$(40,074)$(81,553)
Carrying amount as of June 30, 2024 (Restated)$70,981 $10,552 $81,533 
Amounts related to leases recognized in the Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated) are as follows:
For the six months ended June 30,
20242023
Income from sub-leasing right-of-use assets1,132 527 
Expense relating to short-term leases(269)(495)
Expense relating to lease of low value assets(4)(6)
Interest expense on leases(3,706)(2,166)
The current and non-current portion of the Group’s lease liabilities are as follows:
As of June 30, 2024As of December, 31, 2023
Current lease liability16,857 19,547 
Current lease liabilities - related parties15,039 10,628 
Non-current lease liability43,248 54,439 
Non-current lease liabilities - related parties32,918 42,634 
Total$108,062 $127,248 
Expected future lease payments to be made to satisfy the Group’s lease liabilities are as follows:
F-15
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
As of June 30, 2024As of December, 31, 2023
(Restated)
Within 1 year34,990 32,685 
Between 1 and 2 years32,400 33,275 
Between 2 and 3 years18,551 28,033 
Between 3 and 4 years13,291 18,634 
Between 4 and 5 years9,943 11,463 
Later than 5 years12,035 15,458 
Total$121,210 $139,548 
For the six months ended June 30, 2024, total cash outflows for leases, inclusive of interest paid, amounted to $16,240.
Polestar Group as Lessor
As a lessor, revenue recognized from operating leases is as follows:
For the six months ended June 30,
20242023
Vehicle leasing revenue11,566 7,493 
For the majority of the Group’s operating lease contracts as a lessor, vehicles are paid for upfront by the customer at contract inception and repurchased by Polestar at the end of the lease term. The following table depicts the changes in the Group’s vehicles under operating leases:
Vehicles under operating leases
Acquisition cost
Balance as of January 1, 2024141,448 
Reclassification from inventory43,503 
Reclassification to inventory - (Restated)(44,455)
Effect of foreign currency exchange rate differences(4,716)
Balance as of June 30, 2024 - (Restated)$135,780 
Accumulated depreciation
Balance as of January 1, 2024(71,225)
Reclassification to inventory - (Restated)6,047 
Depreciation expense (2,189)
Effect of foreign currency exchange rate differences1,099 
Balance as of June 30, 2024 - (Restated)$(66,268)
Carrying amount as of June 30, 2024 - (Restated)$69,512 
Note 7 - Net loss per share
The following table presents the computation of basic and diluted net loss per share for the six months ended June 30, 2024 and 2023:
For the six months ended June 30,
20242023
(Restated)
(Restated)
Class A and B Common
Net loss attributable to common shareholders(543,878)(341,543)
Weighted-average number of common shares outstanding:
Basic and diluted2,110,214 2,109,952 
F-16
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Net loss per share (in ones):
Basic and diluted(0.26)(0.16)
The following table presents shares that were not included in the calculation of diluted loss per share as their effects would have been antidilutive for the six months ended June 30, 2024 and 2023:
For the six months ended June 30,
20242023
Earn-out Shares158,177,609 158,177,609 
Class C-1 Shares20,499,965 20,499,965 
Class C-2 Shares4,500,000 4,500,000 
PSUs5,084,454 2,326,794 
RSUs11,752,934 708,968 
Marketing consulting services agreement— 62,500 
RSAs410,746 — 
Total antidilutive shares200,425,708 186,275,836 
Note 8 - Intangible assets and goodwill
The following table depicts the split between Polestar Group’s intangible assets, goodwill and trademarks:
As of June 30, 2024As of December, 31, 2023
(Restated)
Intangible assets1,418,135 1,368,259
Goodwill and trademarks47,767 50,448 
Total$1,465,902 $1,418,707 
Intangible assets were as follows:
Internally developed IPSoftwareAcquired IPTotal
Acquisition cost
Balance as of January 1, 2024310,450 11,380 1,836,487 2,158,317 
Additions - (Restated)1
81,434 356 60,033 141,823 
Effect of foreign currency exchange rate differences - (Restated)(16,575)(842)(85,193)(102,610)
Balance as of June 30, 2024 - (Restated)$375,309 $10,894 $1,811,327 $2,197,530 
Accumulated amortization and impairment
Balance as of January 1, 2024(18,789)(1,548)(769,721)(790,058)
Amortization expense— (689)(3,166)(3,855)
Amortization capitalized into inventory(299)— (11,298)(11,597)
Effect of foreign currency exchange rate differences1,027 104 24,984 26,115 
Balance as of June 30, 2024 - (Restated)$(18,061)$(2,133)$(759,201)$(779,395)
Carrying amount as of January 1, 2024$291,661 $9,832 $1,066,766 $1,368,259 
Carrying amount as of June 30, 2024 - (Restated)$357,248 $8,761 $1,052,126 $1,418,135 
1 – Of $141,823 in additions for the six months ended June 30, 2024, $93,134 has been settled in cash. These $93,134 are included in the $133,049 cash used for investing activities related to additions to intangible assets, and the remaining $51,817 relates to decreases in Trade payables - related parties from prior years which were settled in cash during the six months ended June 30, 2024.
Additions to internally developed IP are primarily related to the Polestar 5 and various other internal programs, such as model year changes, for the six months ended June 30, 2024. Additions of acquired IP during the six months ended June 30, 2024 were primarily related to acquisitions of Polestar 3 IP from Volvo Cars and Polestar 4 IP from Geely. Polestar also acquired IP related to model years changes of the Polestar 2 from Volvo Cars. Refer to Note 15 - Related party transactions for further details.
Changes to the carrying amount of goodwill and trademarks during the period were as follows:
F-17
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
GoodwillTrademarksTotal
Balance as of January 1, 202448,061 2,387 50,448 
Effect of foreign currency exchange rate differences(2,554)(127)(2,681)
Balance as of June 30, 2024$45,507 $2,260 $47,767 
Note 9 - Property, plant, and equipment
As of June 30, 2024, and December 31, 2023, Property, plant and equipment (or "PPE") is recognized in the Unaudited Condensed Consolidated Statement of Financial Position (as restated) with carrying amounts of $556,869 and $476,039, respectively. Of these amounts, $70,981 and $88,322 is related to ROU assets for leased buildings and land, and $10,552 and $10,680 is related to ROU assets for leased machinery and equipment, respectively. Refer to Note 6 - Leases for more details on the Group's ROU assets and operating leases.
Property, plant and equipment was as follows:
Buildings and landMachinery and equipmentMachinery under developmentTotal
Acquisition Cost
Balance as of January 1, 2024 $8,916 $180,945 $251,638 $441,499 
Additions1 - (Restated)
2,732 11,058 101,211 115,001 
Divestments and disposals— (70)— (70)
Reclassifications - (Restated)1,962 111,104 (113,066)— 
Effect of foreign currency exchange differences - (Restated)(269)(6,005)(6,119)(12,393)
Balance as of June 30, 2024 - (Restated)$13,341 $297,032 $233,664 $544,037 
Depreciation and impairment
Balance as of January 1, 2024 (2,709)(61,174)(579)(64,462)
Depreciation expense - (Restated)(1,287)(2,203)— (3,490)
Depreciation capitalized into inventory - (Restated)— (2,000)— (2,000)
Divestments and disposals— 34 — 34 
Effect of foreign currency exchange differences - (Restated)159 1,058 — 1,217 
Balance as of June 30, 2024 - (Restated)$(3,837)$(64,285)$(579)$(68,701)
Carrying amount at June 30, 2024 - (Restated)$9,504 $232,747 $233,085 $475,336 
1 - Of $115,001 in additions for the six months ended June 30, 2024, $64,464 has been settled in cash. These $64,464 are included in the $83,884 in the cash-flow from investing activities related to additions to property, plant and equipment, and the remaining $19,420 relates to decreases in Trade payables - related parties from prior years which were settled in cash during the six months ended June 30, 2024.
Note 10 - Financial instruments
The following table shows the carrying amounts of financial assets and liabilities measured at fair value through profit and loss on a recurring basis:
As of June 30, 2024As of December, 31, 2023
Assets measured at FVTPLLevel 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Other investments
— — 2,285 2,285 — — 2,414 2,414 
Total financial assets measured at FVTPL$— $— $2,285 $2,285 $— $— $2,414 $2,414 
Earn-out rights— — 15,764 15,764 — — 155,402 155,402 
Class C-1 Shares2,870 — — 2,870 4,920 — — 4,920 
Class C-2 Shares— 630 — 630 — 1,080 — 1,080 
Total financial liabilities measured at FVTPL$2,870 $630 $15,764 $19,264 $4,920 $1,080 $155,402 $161,402 
Refer to Note 1 - Overview and basis of preparation and Note 11 - Reverse recapitalization for more details on the financial liabilities related to the Class C Shares and the Earn-out rights.
The following table shows the carrying amounts of financial assets and liabilities measured at amortized cost:
F-18
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
As of June 30, 2024As of December, 31, 2023
Cash and cash equivalents668,911 768,264 
Trade receivables and trade receivables - related parties - (Restated)184,576 187,742 
Accrued income - related parties34,135 152,605 
Restricted cash21,490 1,834 
Other current receivables and other current receivables - related parties18,056 35,496 
Other non-current receivables6,091 9,733 
Total financial assets measured at amortized cost - (Restated)$933,259 $1,155,674 
Current and non-current liabilities to credit institutions - (Restated)2,475,548 2,026,665 
Other non-current interest bearing liabilities and other non-current interest bearing liabilities - related parties - (Restated)1,443,343 1,467,696 
Accrued expenses and accrued expenses - related parties - (Restated)552,093 720,759 
Trade payables and trade payables - related parties - (Restated)485,200 368,145 
Current and non-current liabilities related to repurchase commitments - (Restated)115,864 119,664 
Interest-bearing current liabilities¹ and interest bearing current liabilities - related parties - (Restated)106,827 93,361 
Current and non-current refund liabilities and current refund liabilities - related parties - (Restated)82,264 53,257 
Other current liabilities and other current liabilities - related parties - (Restated)55,418 20,939 
Advance payments from customers18,694 16,415 
Other non-current liabilities11,571 64,990 
Total financial liabilities measured at amortized cost - (Restated)$5,346,822 $4,951,891 
1 – The Group’s current and non-current lease liabilities are included in Interest-bearing current liabilities and Other non-current interest-bearing liabilities, respectively. These amounts are presented separately in Note 6 - Leases.
Total interest income arising on financial assets measured at amortized cost related to cash and cash equivalents for the six months ended June 30, 2024 and 2023 amounted to $5,606 and $12,489, respectively. Total interest expense arising on financial liabilities measured at amortized cost related to liabilities to credit institutions, lease liabilities, other financing obligations, and related party liabilities for the six months ended June 30, 2024 and 2023 amounted to $163,065 and $76,176, respectively.
The following table shows the maturities for the Group’s non-derivative financial assets and liabilities as of June 30, 2024:
Due within 1 yearDue between 1 and 5 yearsDue beyond 5 yearsTotal
Trade receivables and trade receivables - related parties - (Restated)184,576 — — 184,576 
Accrued income - related parties34,135 — — 34,135 
Restricted cash— 21,490 — 21,490 
Other current receivables and other current receivables - related parties18,056 — — 18,056 
Other non-current receivables— 6,091 — 6,091 
Total financial assets - (Restated)$236,767 $27,581 $— $264,348 
Current and non-current liabilities to credit institutions - (Restated)1,539,331 936,217 — 2,475,548 
Other non-current interest bearing liabilities and other non-current interest bearing liabilities - related parties - (Restated)— 1,422,752 20,591 1,443,343 
Accrued expenses and accrued expenses - related parties - (Restated)552,093 — — 552,093 
Trade payables and trade payables - related parties - (Restated)485,200 — — 485,200 
Current and non-current liabilities related to repurchase commitments - (Restated)79,315 36,549 — 115,864 
Interest-bearing current liabilities and interest bearing current liabilities - related parties - (Restated)106,827 — — 106,827 
Current and non-current refund liabilities and current refund liabilities - related parties - (Restated)78,488 3,776 — 82,264 
F-19
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Other current liabilities and other current liabilities - related parties - (Restated)55,418 — — 55,418 
Advance payments from customers18,694 — — 18,694 
Other non-current liabilities— 11,571 — 11,571 
Total financial liabilities - (Restated)$2,915,366 $2,410,865 $20,591 $5,346,822 
Note 11 - Reverse recapitalization
Polestar underwent a reverse recapitalization through the merger with GGI and related arrangements on June 23, 2022. For more detail on the reverse capitalization, including the net assets of GGI assumed by the Group and the Class C Shares and Earn out rights issued in connection with the merger that are accounted for as derivative liabilities in accordance with IAS 32, Financial Instruments: Presentation (“IAS 32”), and IFRS 9, Financial Instruments (“IFRS 9”), refer to Note 1 - Overview and basis of preparation and Note 18 - Reverse recapitalization in the Consolidated Financial Statements for Polestar Automotive Holding UK PLC, as of December 31, 2023 and 2022, and for the three years ended December 31, 2023, that were included in the Form 20-F/A filed with the SEC on April 23, 2025.
Class C Shares
The Class C-1 Shares are publicly traded on the Nasdaq (i.e., Level 1 input) and the closing share price of the GGI Public Warrants on June 23, 2022 was used to measure their fair value upon initial recognition. The Class C-2 Shares are not publicly traded and require a valuation approach leveraging Level 2 inputs. Refer to Note 2 - Significant accounting policies and judgements for further details on the valuation methodology utilized to determine the fair value of the Class C-2 Shares upon initial recognition and subsequently thereafter.
As of June 30, 2024As of December, 31, 2023
Liability Fair ValueNumber OutstandingLiability Fair ValueNumber Outstanding
Class C-1 Shares2,870 20,499,965 4,920 20,499,965 
Class C-2 Shares630 4,500,000 1,080 4,500,000 
Total$3,500 24,999,965 $6,000 24,999,965 
Class C-1 Shares
As of January 1, 20244,920 
Changes in fair value measurement(2,050)
As of June 30, 2024$2,870 
Class C-2 Shares
As of January 1, 20241,080 
Changes in fair value measurement(450)
As of June 30, 2024$630 
The fair value change for the Class C Shares are as follows:
For the six months ended June 30,
20242023
Fair value change - Class C-1 Shares2,050 3,775 
Fair value change - Class C-2 Shares450 6,975 
Fair value change - Class C Shares$2,500 $10,750 
Earn-out rights
Refer to Note 2 - Significant accounting policies and judgements for further details on the valuation methodology utilized to determine the fair value of the earn-out.
Earn out rights
As of January 1, 2024155,402 
Changes in fair value measurement(139,638)
As of June 30, 2024$15,764 
The fair value change for the Earn-out rights are as follows:
F-20
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
For the six months ended June 30,
20242023
Fair value change - Earn-out rights139,638 232,995 
Note 12 - Inventories
The Group’s inventory primarily consisted of vehicles as follows:
As of June 30, 2024As of December, 31, 2023
(Restated)
Finished goods and goods for resale800,680 1,070,897 
Work in progress31 32 
Provision for impairment(86,682)(143,243)
Total$714,029 $927,686 
Inventories recognized as an expense during the six months ended June 30, 2024, and 2023 amounted to $870,699 and $1,155,622, respectively, and were included in Cost of sales in the Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated).
During the six months ended June 30, 2024, and 2023 write-downs of inventories to net realizable value amounted to $31,682, and $11,795 respectively. The write downs were recognized as an expense and were included in Cost of sales in the Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated).
Inventories have been pledged as security for liabilities. Refer to Note 14 - Liabilities to credit institutions for further details.
Note 13 - Equity
Changes in the Group's equity during the six months ended June 30, 2024 were as follows:
Class A SharesClass B SharesShare capitalOther contributed capital
Balance as of January 1, 2024467,976,748 1,642,233,575 (21,168)(3,615,187)
Conversion from Class B to Class A1,592,341,000 (1,592,341,000)— — 
Equity-settled share-based payment - (Restated)144,249 — (1)(6,774)
Balance as of June 30, 2024 - (Restated)2,060,461,997 49,892,575 $(21,169)$(3,621,961)
The following instruments of the Parent were issued and outstanding as of June 30, 2024:
•2,060,461,997 Class A Shares with a par value of $0.01, of which 1,675,841,017 were owned by related parties;
•49,892,575 Class B Shares with a par value of $0.01, of which all were owned by related parties;
•20,499,965 Class C-1 Shares with a par value of $0.10;
•4,500,000 Class C-2 Shares with a par value of $0.10; and
•50,000 Redeemable Preferred Shares with a par value of GBP 1.00.
As of June 30, 2024, there were an additional 2,939,538,003 Class A Shares and 1,727,474,164 Class B Shares with par values of $0.01 authorized for issuance. No additional Class C Shares or Redeemable Preferred Shares were authorized for issuance. Holders of Class A Shares in Parent are entitled to one vote per share and holders of Class B Shares in Parent are entitled to ten votes per share. Holders of Class C Shares in Parent are entitled to one vote per share for certain matters, but have no voting rights with respect to general matters voted on by holders of Class A Shares and Class B Shares in Parent. Additionally, holders of GBP Redeemable Preferred Shares in Parent have no voting rights. Any dividends or other distributions paid by Parent shall be issued to holders of outstanding Class A Shares and Class B Shares in Parent. Holders of Class C Shares and GBP Redeemable Preferred Shares in Parent are not entitled to participate in any dividends or other distributions. Refer to Note 11 - Reverse recapitalization for additional information on the Class C Shares which are accounted for as derivative financial liabilities in accordance with IAS 32 and IFRS 9.
Note 14 - Liabilities to credit institutions
The carrying amount of Polestar Group’s liabilities to credit institutions as of June 30, 2024 and December 31, 2023 are as follows:
F-21
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Liabilities to credit institutionsAs of June 30, 2024As of December 31, 2023
(Restated)
Current
Working capital loans from banks1,438,390 1,923,755 
Floorplan facilities73,269 75,963 
Sale-leaseback facilities27,672 26,947 
Total$1,539,331 $2,026,665 
Non Current
Syndicated loan from banks
936,217 — 
Total$936,217 $— 
Total liabilities to credit institutions$2,475,548 $2,026,665 
The Group has the following current working capital loans outstanding as of June 30, 2024:
CurrencyTermSecurityInterestNominal amount in respective currency (thousands)Amount in USD (thousands)
USDAugust 2023 - August 2024
Unsecured1
3 month SOFR2 plus 2.3% settled quarterly
402,000 402,000 
USDAugust 2023 - August 2024
Secured3
12 month SOFR2 plus 0.9%, settled quarterly
320,000 320,000 
USDAugust 2023 - August 2024
Unsecured1
12 month SOFR2 plus 1.1%, settled quarterly
82,000 82,000 
CNYSeptember 2023 - September 2024
Unsecured1
12 month LPR4 plus 0.25%, settled quarterly
500,000 68,830 
USDSeptember 2023 - September 2024
Unsecured1
12 month SOFR2 plus 0.65%, settled quarterly
118,000 118,000 
USDSeptember 2023 - September 2024
Secured3
12 month SOFR2 plus 1.11% settled semi-annual
100,000 100,000 
CNYOctober 2023 - October 2024
Unsecured1
12 month LPR4 plus 0.15% settled quarterly
200,000 27,532 
CNYDecember 2023 - December 2024
Unsecured1
12 month LPR4 plus 1.05% settled quarterly
92,000 12,665 
USDDecember 2023 - December 2024
Secured3
12 month SOFR2 plus 1.7%, settled semi-annual
133,000 133,000 
EURFebruary 2024 - February 2025
Secured5
3 month EURIBOR6 plus 2.3% and an arrangement fee of 0.15%, settled quarterly
38,290 40,971 
CNYMarch 2024 - March 2025
Unsecured1
12 month LPR4 plus 1.05% settled quarterly
177,000 24,366 
CNYApril 2024 - April 2025
Unsecured7
12 month LPR4 plus 0.35% settled quarterly
473,000 65,113 
CNYMay 2024 - May 2025
Unsecured7
12 month LPR4 plus 0.35% settled quarterly
88,000 12,114 
CNYJune 2024 - June 2025
Unsecured1
12 month LPR4 plus 0.85% settled quarterly
231,000 31,799 
Total$1,438,390 
1 - Letters of keep well from both Volvo Cars and Geely.
2 - Secured Overnight Financing Rate ("SOFR").
3 - Secured by Geely.
4 - People’s Bank of China (“PBOC”) Loan Prime Rate (“LPR").
5 - New vehicle inventory purchased via this facility is pledged as security until repaid. This facility has a repayment period of 90 days and includes a covenant tied to the Group’s financial performance.
6 - Euro Interbank Offered Rate (“EURIBOR”).
7 - Letter of comfort from Geely.
The Group's loan denominated in EUR which has a term of February 2024-February 2025 is subject to covenant requirements, including but not limited to minimum quarterly cash levels of €400,000.
The Group has the following non-current syndicated loan from banks outstanding as of June 30, 2024:
F-22
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
CurrencyTermSecurityInterestNominal amount in
respective currency -
(thousands) - (Restated)		Amount in
USD -
(thousands) - (Restated)
USDFebruary 2024 - February 2027
Unsecured1,2
3 month Term SOFR3 plus 3.35%
576,618 576,618 
EURFebruary 2024 - February 2027
Unsecured1,2
3 month EURIBOR4 plus 2.85%
336,073 359,599 
Total$936,217 
1 - Letter of keep well from Geely and letters of comfort from Volvo Cars and PSD.
2 - The loans are secured by interest reserve accounts pledges with an aggregate of three months interest deposited. The Group had a restricted cash balance of $21,490 as of June 30, 2024.
3 - Term Secured Overnight Financing Rate ("Term SOFR").
4 - Euro Interbank Offered Rate (“EURIBOR”).
The syndicated loan is subject to covenant requirements, including but not limited to a minimum annual revenue of $5,359,900 for 2024, minimum quarterly cash levels of €400,000, and maximum quarterly financial indebtedness of $5,500,000.
Floorplan facilities
In the ordinary course of business, Polestar, on a market-by-market basis, enters into multiple low-value credit facilities with various financial service providers to fund operations related to vehicle sales. These facilities provide access to credit with the option to renew as mutually determined by Polestar Group and the financial service provider. The facilities are partially secured by the underlying assets on a market-by-market basis. As of June 30, 2024 and December 31, 2023, the aggregate amount outstanding under these arrangements was $129,743 and $120,840, respectively.
The Group maintains one such facility with the related party Volvo Cars that is presented separately in Interest-bearing current liabilities - related parties within the Unaudited Condensed Consolidated Statement of Financial Position (as restated). Of the amounts above, the aggregate amount outstanding as of June 30, 2024 and December 31, 2023 due to related parties amounted to $56,475 and $44,877, respectively. Refer to Note 15 - Related party transactions for further details.
Sale-leaseback facilities
Polestar has also entered into contracts to sell vehicles and then lease such vehicles back for a period of up to twelve months. At the end of the leaseback period, Polestar is obligated to re-purchase the vehicles. Accordingly, the consideration received for these transactions was recorded as a financing transaction. As of June 30, 2024 and December 31, 2023, the aggregate amount outstanding under these arrangements were $27,672 and $26,947, respectively.
Since the contracts identified above are short term with a duration of twelve months or less, the carrying amount of the contracts is deemed to be a reasonable approximation of their fair value. The Group’s risk management policies related to debt instruments are further detailed in Note 3 - Financial risk management of the Consolidated Financial Statements, as of December 31, 2023 and 2022, and for the three years ended December 31, 2023 that were included in the Form 20-F/A filed with the SEC on April 23, 2025. There are no changes in terms of risk management policies for the periods presented in these Unaudited Condensed Consolidated Financial Statements.
Note 15 - Related party transactions
For a detailed description of the Group’s related parties and related party transactions, refer to Note 27 - Related party transactions of the Consolidated Financial Statements, as of December 31, 2023 and 2022, and for the three years ended December 31, 2023, that were included in the Form 20-F/A filed with the SEC on April 23, 2025. Related party activity during the six months ended June 30, 2024 and 2023 and balances as of June 30, 2024 and December 31, 2023 are presented below.
Financing
Working capital loans
In May 2021, the Group entered into a working capital credit facility with Volvo Cars and subsequently made draw downs on the facility, which has a maturity of one year. As of June 30, 2024, $56,475 of this financing arrangement remained outstanding, which is included in Interest-bearing current liabilities - related parties on the Unaudited Condensed Consolidated Statement of Financial Position (as restated). Refer to Note 14 - Liabilities to credit institutions for further details.
Convertible instruments
On November 3, 2022 the Group entered into a credit facility agreement with Volvo Cars providing available credit of up to $800,000; originally terminating on May 3, 2024. The credit facility can be drawn upon once a month and is utilizable for general corporate purposes. Interest is calculated at the floating six-month SOFR rate plus 4.9% per annum. Prior to June 30, 2027, if the Group announces an offering of shares with a proposed capital raise of at least $350,000 and no fewer than five institutional investors participate in the offering, Volvo Cars has the right to convert the principal amount of any outstanding loans into the same class of shares and at the same price per share as received by the participating institutional investors. Under IAS 32 and IFRS 9, Volvo Cars' conversion right meets the definition of an embedded derivative financial liability that is required to be bifurcated from the host debt instrument and accounted for separately because it could result in the issuance of a variable number of Class A Shares in the Parent at a price that was not fixed at the inception of the agreement. Additionally, the economics of Volvo Cars' conversion right are not clearly and closely related to that of the host debt instrument because the principal value of Volvo Cars' conversion right depends on (1)
F-23
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
whether or not the Group conducts a qualified equity offering to investors at a market discount and (2) the time-value of money associated with settlement of the liability earlier than June 30, 2027. As such, the financial liability related to Volvo Cars' conversion right is carried at fair value with subsequent changes in fair value recognized in the Consolidated Statement of Loss and Comprehensive Loss at each reporting date. On November 8, 2023, the credit facility agreement was amended to increase the overall credit capacity to $1,000,000 and extend the termination date to June 30, 2027. As a result of the amended terms, Polestar recalculated the carrying amount of the liability as the present value of the modified contractual cash flows and recognized a modification loss of $7,553 within Finance expense for the year ended December 31, 2023. As of June 30, 2024, the Group had principal draw downs of $1,000,000 outstanding under the facility, and the fair value of the financial liability related to Volvo Cars' conversion right was $0.
On November 8, 2023, the Group entered into a credit facility agreement with Geely providing available credit of up to $250,000; terminating on June 30, 2027. Other than the amount of credit available, the credit facility agreement with Geely maintains terms that are identical to the amended credit facility agreement with Volvo Cars. As of June 30, 2024 the Group had principal draws of $250,000 outstanding under the facility and the fair value of the financial liability related to Geely's conversion right was $0.
Other financing instruments
On December 8, 2023, Polestar and Geely entered into an asset transfer agreement which, when considered together with certain other agreements not signed until after December 31, 2023, was designed to provide financing to Polestar in exchange for Polestar transferring legal ownership of certain Polestar unique tooling and equipment that will be used in the manufacturing of the PS3 (the "PS3 Tooling and Equipment") to Geely. As of June 30, 2024, total principal of $129,521 was outstanding under this financing arrangement.
As of June 30, 2024 the total principal balance outstanding under the facilities with Volvo Cars and Geely is reflected within Other current liabilities - related parties and Other non-current interest-bearing liabilities - related parties.
Sale of goods, services and other
The total revenue recognized for each related party was as follows:
For the six months ended June 30,
20242023
(Restated)(Restated)
Polestar Times Technology61,650 — 
Volvo Cars55,025 54,040 
Ziklo Bank AB1
44,038 21,754 
Geely— 1,245 
Total$160,713 $77,039 
1- In March 2024, Volvofinans Bank AB changed its name to Ziklo Bank AB.
For the six months ended June 30, 2024, revenue from related parties amounted to $160,713 (17.7%) of total revenue. For the six months ended June 30, 2023, revenue from related parties amounted to $77,039 (6.2%) of total revenue.
Purchases of goods, services and other
The total purchases of goods services and other for each related party were as follows:
For the six months ended June 30,
20242023
(Restated)(Restated)
Volvo Cars446,429 1,228,668 
Geely186,650 84,815 
Renault Korea Motors Co. Ltd5,135 — 
Zheijiang C2M Digital Technology Co. Ltd815 — 
Ziklo Bank AB230 312 
Wuxi InfiMotion Propulsion Technology Co., Ltd.,17 6,922 
Total$639,276 $1,320,717 
Cost of R&D and intellectual property
Polestar Group has R&D transactions with Volvo Cars and Geely (joint development, IP owned by VCC vs. Polestar and related license rights, fixed price contracting, supplier recovery, etc). Polestar has entered into agreements with Volvo and Geely regarding the development of technology for upgrades of existing models; as well as for upcoming models. The technology can be either Polestar unique or commonly shared. In both cases, Polestar is in control of the developed product through a license or through ownership of the IP. The recognized asset associated with these agreements as of June 30, 2024 was $1,052,126, of which acquisitions attributa
F-24
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
ble to 2024 were approximately $60,033. As of December 31, 2023, the recognized asset associated with these agreements was $1,066,766, of which acquisitions attributable to 2023 were $241,048.
Amounts due to related parties
Amounts due to related parties were as follows:
Trade payables - related parties, accrued expenses, and other current liabilities - related partiesAs of June 30, 2024As of December, 31, 2023
(Restated)
Volvo Cars417,647 494,170 
Geely196,976 195,255 
Ziklo Bank AB1,347 2,124 
Volvo Car Financial Services UK5,332 751 
Polestar Times Technology4,028 30,668 
Total$625,330 $722,968 
Interest bearing current liabilities - related partiesAs of June 30, 2024As of December, 31, 2023
(Restated)
Volvo Car Financial Services UK56,475 44,878 
Geely18,456 18,308 
Volvo Cars15,039 10,628 
Total$89,970 $73,814 
Other non-current interest-bearing liabilities - related partiesAs of June 30, 2024As of December, 31, 2023
(Restated)
Volvo Cars1,039,029 1,049,828 
Geely361,066 363,429 
Total$1,400,095 $1,413,257 
The Group’s interest expense from related parties is as follows:
For the six months ended June 30,
20242023
(Restated)
Interest expense - related parties73,651 25,782 
Amounts due from related parties
Amounts due from related parties were as follows:
Trade receivables - related parties, accrued income - related parties, and other current assets - related partiesAs of June 30, 2024As of December, 31, 2023
Geely43,033 44,979 
Volvo Cars19,088 167,989 
Ziklo Bank AB5,126 954 
Wuhan Lotus Cars Co., LTD.4,336 4,574 
Polestar Times Technology2,688 4,177 
Volvo Car Financial Services UK1,010 534 
Total$75,281 $223,207 
F-25
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Note 16 - Commitments and contingencies
Commitments
As of June 30, 2024, commitments to acquire PPE and intangible assets were $40,035 and $9,077, respectively. As of December 31, 2023, commitments to acquire PPE and intangible assets were $42,288 and $31,338, respectively. These commitments are contractual obligations to invest in PPE and intangible assets for the production of upcoming vehicle models Polestar 3, Polestar 4, Polestar 5 and Polestar 6. As of June 30, 2024 and December 31, 2023, Polestar also had a capital injection commitment related to the investment in Polestar Times Technology amounting to $0 and $68,600, respectively. Refer to Note 5 - Investment in associates for more details on the investment in Polestar Times Technology.
Polestar has signed contracts with certain suppliers including a non-cancellable commitment, an agreed minimum purchase volume, or an agreed minimum sales volume. In the event of a shortfall in purchases, a shortfall in sales, or Polestar´s decision to terminate such contracts, these suppliers are entitled to compensation from Polestar. The amounts in the table below represent Polestar´s future commitments as of June 30, 2024:
TotalLess than 1 yearBetween 1-5 yearsAfter 5 years
PS2 battery purchase volume commitments91,193 44,566 46,627 — 
Logistics service commitments38,364 38,364 — — 
PS3 and PS4 purchase volume commitments - (Restated)207,660 41,326 151,485 14,849 
PS4 sales volume commitments80,885 13,483 60,069 7,333 
Total - (Restated)$418,102 $137,739 $258,181 $22,182 
Contingencies
In the normal course of business, the Group is subject to contingencies related to legal proceedings, claims, and other assessments that cover a wide range of matters. Liabilities for such contingencies are not recorded until it is probable that a present obligation exists and the amount of the obligation can be estimated reliably. However, contingencies are disclosed when the potential financial effect could be material. As of June 30, 2024 and December 31, 2023, the Group did not have any material contingencies.
Note 17 - Subsequent events
Management has evaluated events subsequent to June 30, 2024 and through September 30, 2024, the date these Unaudited Condensed Consolidated Financial Statements were originally authorized for issuance by the Board of Directors. The following events which occurred subsequent to June 30, 2024 merited disclosure in these Unaudited Condensed Consolidated Financial Statements. Management determined that no adjustments were required to the figures presented as a result of these events.
On August 2, 2024, Polestar entered into an 11-month working capital loan for $196,000 with China CITIC Bank Hangzhou Branch. This loan carries an interest rate of 7.8% per annum due quarterly. This loan benefits from letters of comfort from Geely.
On August 20, 2024, Polestar entered into a 12-month revolving credit facility with Standard Chartered Bank (Hong Kong) Limited ("SCB") for an aggregate principal amount of up to $300,000. Each draw of this facility carries interest at a rate of the 3-month Term SOFR plus 1% per annum, 12-month Term SOFR plus 1.2% per annum, or otherwise as mutually agreed at each draw down. All draws under this revolving credit facility are secured by Geely. On August 23, 2024 and September 9, 2024, Polestar borrowed $100,000 and $100,000, respectively, under the facility. Both draws carry interest at the 12-month Term SOFR plus 1.2% per annum and have a repayment period of 12 months. On September 27, 2024, Polestar borrowed $100,000 under the facility. The draw carries interest at the 1-month Term SOFR plus 1% per annum and has a repayment period of 7 days, as mutually agreed upon by both parties.
On August 21, 2024, Polestar entered into an amended facilities agreement (“Second Amended Agreement”) with Volvo Cars pertaining to the credit agreement signed on November 3, 2022 (“Original Agreement”) and amended on November 8, 2023 (“Amended Agreement”). Under the Original Agreement, Polestar had $800,000 in borrowing capacity and under the Amended Agreement, Polestar was provided an additional $200,000 line of credit. As of the date these financial statements were ready for issuance, Polestar had drawn down on all $1,000,000 of available credit. The Second Amended Agreement extends the loan’s maturity date from June 30, 2027 to December 29, 2028. Interest will be calculated using the floating 6-month SOFR rate plus 4.9% per annum.
On August 27, 2024, Polestar entered into a 12-month working capital loan for $320,000 with PingAn Bank. This loan carries an interest rate of 12-month SOFR plus 0.55% due quarterly. This loan is secured by Geely.
On August 28, 2024, Polestar entered into a 12-month working capital loan for $82,000 with PingAn Bank. This loan carries an interest rate of 12-month SOFR plus 0.55% due quarterly. This loan benefits from letters of comfort from Geely.
On September 6, 2024, Polestar and Volvo Car USA LLC, a Volvo Cars subsidiary, entered into an agreement for the manufacturing of Polestar 3 vehicles in Volvo Cars' Charleston plant. Under this agreement, Polestar is committed to purchase certain volumes of Polestar 3 vehicles between 2024 and 2031. In the event that Polestar´s actual volumes purchased during the production period are lower than the agreed volumes, Polestar is obligated to compensate Volvo Cars for fixed costs related to the lost capacity.
On September 16, 2024, Polestar entered into a 12-month revolving green trade facility with Banco Bilbao Vizcaya Argentaria, S.A., Hong Kong Branch ("BBVA") for an aggregate principal amount of up to $150,000, available for drawdown in EUR or USD. All draws under this revolving credit facility are secured by Geely. On September 19, 2024, Polestar borrowed $100,000 under the facility. This draw carries interest at the 12-month Term SOFR plus 1.1% and has a repayment period of 12 months. On
F-26
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
September 27, 2024, Polestar borrowed an additional $50,000 under the facility. This draw carries interest at the 1-month Term SOFR plus 1.1% and has a repayment period of 7 days, as mutually agreed upon by both parties.
On September 19, 2024, Polestar entered into a 6-month working capital loan for $100,000 with China CITIC Bank Hangzhou Branch. This loan carries an interest rate of 6.9% per annum due monthly. This loan is secured by Geely.
On September 26, 2024, Polestar entered into a 9-month working capital loan for $104,000 with China CITIC Bank Hangzhou Branch. This loan carries an interest rate of 7.8% per annum due quarterly. This loan benefits from letters of comfort from Geely.
Note 18 - Restatement of prior period unaudited interim financial statements
Prior Restatement
In connection with the preparation of our consolidated financial statements as of and for the year ended December 31, 2023, management identified various misstatements in our previously issued 2021 and 2022 annual financial statements and 2023 interim financial statements. In these Unaudited Condensed Consolidated Financial Statements, the Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated) and the Unaudited Condensed Consolidated Statement of Cash Flows (as restated) for the six months ended June 30, 2023, have been restated to align to the revisions during 2023 to correct for the carryforward impacts of the misstatements in our previously issued 2021 and 2022 annual financial statements. The errors relate to the following categories of misstatements:
(i) Inventories
The errors identified in the Inventories category encompass errors relating to incorrect valuation, classification, recognition, and allocation of costs associated with inventory. The most significant errors in this category include the incorrect treatment of certain launch costs, capitalization of inventory cost allocation, failed sale/lease transactions, and vehicles with repurchase obligations. The impact to the Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated) of the inventory related error corrections was an increase in the loss by $23,662.
(ii) Accruals and Deferrals
The errors identified in the Accruals and Deferrals category encompass errors relating to the recognition and measurement of accruals and deferrals. These errors include both the understatement and overstatement of accruals and deferrals before the issuance of the financial statements, despite the availability of accurate information. The most significant transactions in this category include incorrect warranty accrual release, over accrual of operating expenses in North America and timing of revenue recognition and deferred revenue related to vehicle subscription services. The impact to the Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated) of the accrual and deferral related error corrections was an increase in the loss by $10,711.
(iii) Capitalization of expenses
The errors identified in the Capitalization of Expenses category encompass errors relating to expenses that were erroneously capitalized as an asset and vice-versa. The most significant transactions in this category include incorrect recognition of certain assets in China, and the incorrect capitalization of manufacturing engineering expenses as an intangible asset related to services provided to certain contract manufacturing facilities. The impact to the Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated) of the capitalization related error corrections was a reduction of the loss of $10,376.
(iv) Other - Reclassifications
The errors identified in the Other - Reclassifications category encompass errors arising from misallocations of assets and liabilities between different financial statement captions and misallocations of assets and liabilities between current and non-current. The most significant adjustments in this category include non-current reclassification misstatements related to certain buyback liabilities, an error in lease asset and liability in the United Kingdom, a reclassification of internally developed IP to software, and a reclassification of goods received not invoiced from trade payables to other current liabilities. There is a marginal impact to the Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated) due to reclassifications relating to lease expense reversals upon the reclassification of a lease liability to a financing obligation in Korea.
(v) Deferred Taxes and Income Taxes
The errors identified in the Deferred Taxes and Income Taxes category encompass errors relating to the recognition, measurement, and reporting of the Group’s deferred tax assets, deferred tax liabilities, and income tax expenses. These errors include improper estimation of deferred tax amounts, errors in tax calculations, and errors pertaining to the treatment of value added tax. The most significant transactions in this category include incorrect recognition of deferred tax assets and deferred liabilities at the Sweden tax rate, instead of the local market rate, and incorrect recording of deferred taxes and income tax expense in North America resulting from the other misstatement categories explained. The tax impact of all misstatement corrections has also been recognized. The impact to the Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated) of the tax related error corrections and the tax effect of the other error corrections was an increase in the loss of $4,330.

Current Restatement
Subsequent to the issuance of the Unaudited Condensed Consolidated Financial Statements included within the Form 6-K for the six months ended June 30, 2024, management identified misstatements in connection with the preparation of our Consolidated Financial Statements as of and for the year ended December 31, 2024 that warranted the restatement of the interim 2024 Unaudited Condensed Consolidated Financial Statements. The Current Restatement relates to the following misstatements:
(vi) Unique Tooling Assets Under Construction
F-27
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
This error is the primary reason for the restatement decision. The Company owns unique tooling which is used in the manufacturing of its vehicles. This unique tooling had previously been recognized as property, plant and equipment once either the production standard part process test is conducted or production utilizing the unique vendor tools has occurred, whichever is earlier. Management determined due to contractual terms that certain unique tooling should have instead been recognized as assets under construction (“AUC”) in the Property, plant, and equipment financial statement caption according to the progression of work, resulting in a material understatement of AUC and a corresponding understatement of Other current liabilities in the Unaudited Condensed Consolidated Statement of Financial Position as of June 30, 2024 in the amount of $8,093. The reconsideration of the AUC recognition changes the timing of recognizing AUC but does not change the expected total amount of property, plant, and equipment to be acquired. There is no impact on the interim 2024 and 2023 Unaudited Condensed Consolidated Statements of Loss and Comprehensive Loss as a result of the AUC misstatement.
(vii) Reclassification of Cash Flows
There was a classification error between investing and operating activities in the Unaudited Condensed Statement of Cash Flows related to cash paid for intellectual property (IP). While this error had no impact to the interim 2024 and 2023 Unaudited Condensed Consolidated Statements of Loss and Comprehensive Loss, it led to an overstatement of cash used for investing activities and an understatement of cash used for operating activities in the amount of $93,141 for the six months ended June 30, 2024. This error had no impact on the Unaudited Condensed Statement of Cash Flows for the six months ended June 30, 2023.
(viii) Other – Reclassifications
The errors identified in the Other – Reclassification category encompass errors arising from misallocations of assets and liabilities between different financial statement captions, misallocations of assets and liabilities between current and non-current and misallocations of revenue and expenses. There is no resulting impact on the net loss or total comprehensive net loss included in the interim 2024 and 2023 Unaudited Condensed Consolidated Statements of Loss and Comprehensive Loss, respectively, from correcting these errors.
(ix) Other – Miscellaneous
The errors identified in the Other – Miscellaneous category encompass several insignificant errors that were corrected as part of the restatement process. These errors have an immaterial impact on the interim 2024 and 2023 Unaudited Condensed Consolidated Statements of Loss and Comprehensive Loss. The errors in this category relate to vehicles with repurchase obligations errors, tax calculation errors, as well as both the understatement and overstatement of accruals and other provisions.
The tables below present the effect of the correction of the misstatements on the Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss (as restated) for the six months ended June 30, 2024, and June 30, 2023, Unaudited Condensed Consolidated Statement of Financial Position (as restated) as of June 30, 2024, and Unaudited Condensed Consolidated Statement of Cash Flows (as restated) for the six months ended June 30, 2024, and June 30, 2023.

Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss for the six months ended June 30, 2024
ParticularsAs originally filed on September 30, 2024Current Restatement AdjustmentsAs RestatedCurrent Restatement Reference
Revenue905,8133,434909,247 (viii), (ix)
Cost of sales(933,111)578(932,533) (viii), (ix)
Gross (loss) profit$(27,298)$4,012$(23,286)
Selling, general and administrative expense(437,840)(12,625)(450,465) (viii), (ix)
Research and development expense(23,345)(967)(24,312) (viii), (ix)
Other operating income, net24,034(2,121)21,913 (ix)
Operating loss$(464,449)$(11,701)$(476,150)
Finance income5,6062,4718,077 (ix)
Finance expense(201,427)2,149(199,278) (ix)
Fair value change - Earn-out rights139,638—139,638
Fair value change - Class C Shares2,500 — 2,500 
Share of losses in associates(4,350)—(4,350)
Loss before income taxes$(522,482)$(7,081)$(529,563)
Income tax expense(17,003)2,688(14,315)(ix)
Net loss$(539,485)$(4,393)$(543,878)
Net loss per share (in U.S. dollars)
F-28
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Class A - Basic and Diluted(0.26)— (0.26)
Class B - Basic and Diluted(0.26)— (0.26)
Consolidated Statement of Comprehensive Loss
Net loss(539,485)(4,393)(543,878)
Other comprehensive (loss) income:
Items that may be subsequently reclassified to the Consolidated Statement of Loss:
Exchange rate differences from translation of foreign operations(23,823)16(23,807)(ix)
Total other comprehensive (loss) income(23,823)16(23,807)
Total comprehensive loss(563,308)(4,377)(567,685)
Unaudited Condensed Consolidated Statement of Financial Position as of June 30, 2024
ParticularsAs originally filed on September 30, 2024Current Restatement AdjustmentsAs RestatedCurrent Restatement Reference
Assets
Non-current assets
Intangible assets and goodwill1,458,199 7,703 1,465,902  (viii)
Property, plant and equipment547,098 9,771 556,869  (vi), (ix)
Vehicles under operating leases69,178 334 69,512  (viii)
Other non-current assets27,581 — 27,581 
Deferred tax assets31,759 5,299 37,058  (viii)
Other investments2,285 — 2,285 
Total non-current assets$2,136,100 $23,107 $2,159,207 
Current assets
Cash and cash equivalents668,911 — 668,911 
Trade receivables145,823 511 146,334  (ix)
Trade receivables - related parties38,242 — 38,242 
Accrued income - related parties34,135 — 34,135 
Inventories726,017 (11,988)714,029  (viii)
Current tax assets14,261 — 14,261 
Other current assets210,248 16,458 226,706  (viii)
Other current assets - related parties2,904 — 2,904 
 Total current assets $1,840,541 $4,981 $1,845,522 
Total assets$3,976,641 $28,088 $4,004,729 
Equity
Share capital(21,169)— (21,169)
Other contributed capital(3,621,261)(700)(3,621,961) (ix)
Foreign currency translation reserve49,833 (387)49,446  (viii), (ix)
Accumulated deficit5,412,129 (6,544)5,405,585  (viii), (ix)
Total equity$1,819,532 $(7,631)$1,811,901 
Liabilities
Non-current liabilities
Non-current contract liabilities(62,097)2,446 (59,651) (ix)
Deferred tax liabilities(3,530)— (3,530)
Other non-current provisions(97,772)(26)(97,798) (ix)
Other non-current liabilities(48,119)(3,777)(51,896) (ix)
F-29
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Earn-out liability(15,764)— (15,764)
Non-current liabilities to credit institutions(947,289)11,072 (936,217) (viii)
Other non-current interest-bearing liabilities(43,248)— (43,248)
Other non-current interest-bearing liabilities - related parties(1,384,056)(16,039)(1,400,095) (viii)
Total non-current liabilities$(2,601,875)$(6,324)$(2,608,199)
Current liabilities
Trade payables(80,967)— (80,967)
Trade payables - related parties(401,416)(2,817)(404,233) (viii), (ix)
Accrued expenses - related parties(208,296)9,326 (198,970) (viii), (ix)
Advance payments from customers(18,694)— (18,694)
Current provisions(87,097)1,604 (85,493) (ix)
Current liabilities to credit institutions(1,536,819)(2,512)(1,539,331) (ix)
Current tax liabilities(7,149)997 (6,152) (viii)
Interest-bearing current liabilities(16,857)— (16,857)
Interest-bearing current liabilities - related parties(102,264)12,294 (89,970) (ix)
Current contract liabilities(109,975)58,882 (51,093) (ix)
Class C Shares liability(3,500)— (3,500)
Other current liabilities(599,887)(91,157)(691,044) (vi), (viii), (ix)
Other current liabilities - related parties(21,377)(750)(22,127) (ix)
Total current liabilities$(3,194,298)$(14,133)$(3,208,431)
Total liabilities$(5,796,173)$(20,457)$(5,816,630)
Total equity and liabilities$(3,976,641)$(28,088)$(4,004,729)
Unaudited Condensed Consolidated Statement of Cash Flows as of June 30, 2024
ParticularsAs originally filed on September 30, 2024Current Restatement AdjustmentsAs RestatedCurrent Restatement Reference
Cash flows from operating activities
 Net loss (539,485)(4,393)(543,878) (ix)
 Adjustments to reconcile net loss to net cash flows: ———
 Depreciation and amortization expense 22,37139822,769(viii)
 Warranty provisions 8,612858,697 (ix)
 Impairment of inventory 27,1324,55031,682 (ix)
 Finance income (5,606)(2,471)(8,077)(ix)
 Finance expense 201,427(2,149)199,278 (viii), (ix)
 Fair value change - Earn-out rights (139,638)—(139,638)
 Fair value change - Class C Shares (2,500)—(2,500)
 Income tax expense 17,003(2,688)14,315(ix)
 Share of losses in associates 4,350—4,350
 Loss on derecognition and disposal of property, plant, and equipment and intangible assets ———
Litigation provisions—2,7842,784 (ix)
 Other provisions 13,3212,50515,826 (ix)
 Unrealized exchange gain on trade payables (5,629)—(5,629)
 Other non-cash expense and income 6,6271,0007,627 (ix)
 Change in operating assets and liabilities: ———
 Inventories 163,488(2,675)160,813(viii), (ix)
 Contract liabilities 1,91322,29124,204 (viii)
F-30
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
 Trade receivables, prepaid expenses, and other assets 115,560(16,937)98,623 (viii), (ix)
 Trade payables, accrued expenses, and other liabilities 97,113(100,309)(3,196) (vii), (viii), (ix)
 Interest received 5,606—5,606
 Interest paid (146,199)—(146,199)
 Taxes paid (15,128)—(15,128)
 Cash used for operating activities $(169,662)$(98,009)$(267,671)
 Cash flows from investing activities
 Additions to property, plant, and equipment (83,884)—(83,884)
 Additions to intangible assets (236,935)103,886(133,049) (vii), (ix)
 Additions to investment in associates (34,300)—(34,300)
Additions to other non-current assets—(21,490)(21,490)(viii)
 Proceeds from sale of property, plant, and equipment 34—34
 Cash used for investing activities $(355,085)$82,396$(272,689)
 Cash flows from financing activities
 Change in restricted deposits (20,369)20,369—(viii)
 Proceeds from short-term borrowings 394,640(6,220)388,420 (viii), (ix)
 Proceeds from long-term borrowings 950,6322,122952,754 (viii)
 Repayments of borrowings (867,249)—(867,249)
 Repayments of lease liabilities (12,534)—(12,534)
 Cash provided by financing activities $445,120$16,271$461,391
 Effect of foreign exchange rate changes on cash and cash equivalents (20,389)5(20,384)(ix)
 Net (decrease) increase in cash and cash equivalents $(100,016)$663$(99,353)(ix)
 Cash and cash equivalents at the beginning of the period $768,927$(663)$768,264(ix)
 Cash and cash equivalents at the end of the period $668,911$—$668,911
Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss for the six months ended June 30, 2023
ParticularsAs originally filed on September 30, 2024Restatement in withdrawn financial statementsAs originally restatedRestatement adjustments for Amended 6-KAs RestatedPrior Restatement ReferenceCurrent Restatement Reference
Revenue1,231,2656,3701,237,635(1,270)1,236,365(i),(ii),(iv)(viii)
Cost of sales(1,213,654)(2,366)(1,216,020)1,270(1,214,750)(i),(ii),(iii),(iv)(viii)
Gross profit$17,611$4,004$21,615$—$21,615
Selling, general and administrative expense(448,632)(25,975)(474,607)—(474,607)(i),(ii),(iv)
Research and development expense(81,311)(1,739)(83,050)—(83,050)(ii),(iii)
Other operating expense, net38,581(22)38,559—38,559(i)
Operating loss$(473,751)$(23,732)$(497,483)$—$(497,483)
Finance income12,489—12,489—12,489
Finance expense(90,516)(2,140)(92,656)(2,307)(94,963)(i),(iv)(ix)
F-31
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Fair value change - Earn-out rights232,995—232,995—232,995
Fair value change - Class C Shares10,750 — 10,750 — 10,750 
Loss before income taxes$(308,033)$(25,872)$(333,905)$(2,307)$(336,212)
Income tax expense(5,002)(1,923)(6,925)1,594(5,331)(iv),(v)(viii), (ix)
Net loss$(313,035)$(27,795)$(340,830)$(713)$(341,543)
 Net loss per share (in U.S. dollars)
Class A - Basic and Diluted(0.15)(0.01)(0.16)— (0.16)
Class B - Basic and Diluted(0.15)(0.01)(0.16)— (0.16)
Consolidated Statement of Comprehensive Loss
Net loss(313,035)(27,795)(340,830)(713)(341,543)
Other comprehensive income:
Items that may be subsequently reclassified to the Consolidated Statement of Loss:
Exchange rate differences from translation of foreign operations(26,735)(923)(27,658)156(27,502)(i), (ii), (iii), (iv), (v)(ix)
Total other comprehensive (loss) income(26,735)(923)(27,658)156(27,502)
Total comprehensive loss$(339,770)$(28,718)$(368,488)$(557)$(369,045)
Unaudited Condensed Consolidated Statement of Cash Flows for the six months ended June 30, 2023
ParticularsAs originally filed on September 30, 2024Restatement in withdrawn financial statementsAs originally restatedRestatement adjustments for Amended 6-KAs RestatedPrior Restatement ReferenceCurrent Restatement Reference
Cash flows from operating activities
Net loss(313,035)(27,795)(340,830)(713)(341,543) (i), (ii), (iii), (iv), (v) (ix)
Adjustments to reconcile net loss to net cash flows:
Depreciation and amortization57,074(3,870)53,204—53,204 (i), (ii), (iii)
Warranties36,003(1,384)34,619(3)34,616 (i) (ix)
Impairment of inventory11,795—11,795—11,795
Finance income(12,489) - (12,489)—(12,489)
Finance expense90,5162,14092,6562,30794,963 (i), (iv)  (viii), (ix)
F-32
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Fair value change - Earn-out rights(232,995) - (232,995)—(232,995)
Fair value change - Class C Shares(10,750) - (10,750)—(10,750)
Income tax expense5,0021,9236,925(1,594)5,331 (iv), (v) (viii), (ix)
Disposals and derecognition of property plant and equipment and intangible assets—2,0702,070—2,070 (iv)
Other provisions - 14,87314,873—14,873 (iv)
Unrealized Exchange Gain/Loss Operating Payables - (5,022)(5,022)—(5,022) (iv)
Other non-cash expense and income19,252(11,855)7,397—7,397 (iv)
Change in operating assets and liabilities:—————
Inventories(206,373)17,172(189,201)—(189,201) (i), (iii), (iv)
Contract liabilities24,673(3,510)21,1635,79226,955 (i), (ii), (iv)  (viii)
Trade receivables, prepaid expenses, and other assets72,372(3,684)68,688(8,354)60,334 (i), (iv)  (viii)
Trade payables, accrued expenses, and other liabilities(154,206)19,440(134,766)(3,939)(138,705) (i), (ii), (iii), (iv)  (viii), (ix)
Interest received12,489—12,489—12,489
Interest paid(48,667) - (48,667)—(48,667)
Taxes paid(11,401) - (11,401)—(11,401)
Cash used for operating activities$(660,740)$498$(660,242)$(6,504)$(666,746)
Cash flows from investing activities
Additions to property, plant, and equipment(42,948)—(42,948)—(42,948)
Additions to intangible assets(239,850)1,920(237,930)—(237,930)  (iii)
Proceeds from the sale of property, plant and equipment1,710—1,710—1,710
Cash used for investing activities$(281,088)$1,920$(279,168)$—$(279,168)
Cash flows from financing activities
Proceeds from short-term borrowings1,671,964—1,671,9646,4171,678,381 (viii)
Principal repayments of short-term borrowings(598,953) - (598,953)—(598,953)
Principal repayments of lease liabilities(9,045)(2,526)(11,571)—(11,571) (i), (iv)
Cash provided by financing activities$1,063,966$(2,526)$1,061,440$6,417$1,067,857
Effect of foreign exchange rate changes on cash and cash equivalents(38,603)108(38,495)87(38,408) (i), (ii), (iii), (iv), (v) (ix)
Net (decrease) increase in cash and cash equivalents$83,535$—$83,535$—$83,535
F-33
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands of U.S. dollars unless otherwise stated)
Cash and cash equivalents at the beginning of the period$973,877$—$973,877$—$973,877
Cash and cash equivalents at the end of the period$1,057,412$—$1,057,412$—$1,057,412
In addition to the corrections made to the consolidated financial statements in the tables above, certain items and disclosures have been updated in the financial statements as a result of the misstatements.
F-34

Source: View Original Filing on SEC EDGAR

FAQ

What agreement did Kura Oncology (KURA) announce in its 8-K?

Kura entered a Co-Promotion and Medical Affairs Agreement with Kyowa Kirin US for U.S. commercialization of ziftomenib.

Which product is covered by the Kyowa Kirin co-promotion deal?

The agreement focuses on ziftomenib, Kura’s oral menin inhibitor for acute myeloid leukemia and other hematologic cancers.

How will costs be allocated between Kura and Kyowa Kirin under the agreement?

The parties will share all U.S. co-promotion and medical affairs costs equally (50/50).

Who leads medical affairs for ziftomenib in the United States?

Kura Oncology will lead medical affairs while collaborating with Kyowa Kirin US on strategy and execution.

When can the Co-Promotion Agreement be terminated?

It ends upon mutual cessation of commercialization, expiration of U.S. collaboration term, automatic termination with the master agreement, or for uncured material breach.

Where will the full Co-Promotion Agreement be available?

Kura plans to file the contract, with confidential terms redacted, as an exhibit to its Form 10-Q for the quarter ending June 30, 2025.
Stock PSNYW logo
Polestar Automotive Holding UK Ltd

NASDAQ:PSNYW

PSNYW Rankings

#2656 Ranked by Market Cap
N/A Ranked by Dividends

PSNYW Latest News

Jun 16, 2025
Polestar announces USD 200 million equity investment
Jun 3, 2025
Polestar Sets Date for AGM and Announces Board Changes
May 12, 2025
Polestar reports Q1 2025 revenue growth of 84% and significant gross margin improvement to positive
May 9, 2025
Polestar Sets the Date for Q1 2025 Select Results
Apr 30, 2025
Polestar provides updates on financial guidance for 2025 and 2024 20-F

PSNYW Latest SEC Filings

Jun 30, 2025
[6-K] Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) Current Report (Foreign Issuer)
Jun 20, 2025
[6-K] Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) Current Report (Foreign Issuer)
Jun 18, 2025
[SCHEDULE 13D/A] Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) SEC Filing

PSNYW Stock Data

306.00M
20.50M
4.19%
Auto Manufacturers
Consumer Cyclical
Link
Sweden
Gothenburg